<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Psychiatry</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-0640</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">37265553</article-id>
      <article-id pub-id-type="pmc">10230054</article-id>
      <article-id pub-id-type="doi">10.3389/fpsyt.2023.1102368</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Psychiatry</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Resting state connectivity in people living with HIV before and after stopping heavy drinking</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Gullett</surname>
            <given-names>Joseph M.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref>
          <xref rid="fn0001" ref-type="author-notes">
<sup>†</sup></xref>
          <uri xlink:href="https://loop.frontiersin.org/people/102470/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DeFelice</surname>
            <given-names>Jason</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="fn0001" ref-type="author-notes">
<sup>†</sup></xref>
          <uri xlink:href="https://loop.frontiersin.org/people/2189240/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Richards</surname>
            <given-names>Veronica L.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref>
          <uri xlink:href="https://loop.frontiersin.org/people/2121774/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porges</surname>
            <given-names>Eric C.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cohen</surname>
            <given-names>Ronald A.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <uri xlink:href="https://loop.frontiersin.org/people/202444/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Govind</surname>
            <given-names>Varan</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref>
          <uri xlink:href="https://loop.frontiersin.org/people/524500/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salan</surname>
            <given-names>Teddy</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Yan</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Zhi</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cook</surname>
            <given-names>Robert L.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Center for Cognitive Aging and Memory, Department of Clinical and Health Psychology, University of Florida</institution>, <addr-line>Gainesville, FL</addr-line>, <country>United States</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Department of Epidemiology, University of Florida</institution>, <addr-line>Gainesville, FL</addr-line>, <country>United States</country></aff>
      <aff id="aff3"><sup>3</sup><institution>Edna Bennett Pierce Prevention Research Center, The Pennsylvania State University</institution>, <addr-line>University Park, PA</addr-line>, <country>United States</country></aff>
      <aff id="aff4"><sup>4</sup><institution>Department of Radiology, University of Miami Miller School of Medicine</institution>, <addr-line>Miami, FL</addr-line>, <country>United States</country></aff>
      <aff id="aff5"><sup>5</sup><institution>University of Miami</institution>, <addr-line>Coral Gables</addr-line>, <country>United States</country></aff>
      <author-notes>
        <fn id="fn00001" fn-type="edited-by">
          <p>Edited by: Johannes Petzold, University Hospital Carl Gustav Carus, Germany</p>
        </fn>
        <fn id="fn0002" fn-type="edited-by">
          <p>Reviewed by: Eva M. Muller-Oehring, Stanford University, United States; Tae Joon Moon, The University of Texas Health Science Center at San Antonio, United States; Sara Blaine, Auburn University, United States</p>
        </fn>
        <corresp id="c001">*Correspondence: Joseph M. Gullett, <email>gullettj@phhp.ufl.edu</email></corresp>
        <fn id="fn0001" fn-type="equal">
          <p><sup>†</sup>These authors share first authorship</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>5</month>
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <volume>14</volume>
      <elocation-id>1102368</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>11</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2023 Gullett, DeFelice, Richards, Porges, Cohen, Govind, Salan, Wang, Zhou and Cook.</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>Gullett, DeFelice, Richards, Porges, Cohen, Govind, Salan, Wang, Zhou and Cook</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Heavy alcohol use in people living with HIV (PLWH) has widespread negative effects on neural functioning. It remains unclear whether experimentally-induced reduction in alcohol use could reverse these effects. We sought to determine the effects of 30-days drinking cessation/reduction on resting state functional connectivity in people with and without HIV.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Thirty-five participants (48.6% PLWH) demonstrating heavy alcohol use attempted to stop drinking for 30 days via contingency management (CM). MRI was acquired at baseline and after thirty days, and functional connectivity across five resting-state fMRI (rsfMRI) networks was calculated with the Conn toolbox for Matlab and examined in relation to transdermal alcohol concentration (TAC) recorded by the ankle-worn secure continuous remote alcohol monitor (SCRAM) and self-reported alcohol use (timeline follow-back; TLFB). Associations between alcohol use and reduction, HIV status, functional connectivity, and change in functional connectivity across five major rsfMRI networks were determined relative to the pre- and post-CM timepoints.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Baseline resting-state functional connectivity was not significantly associated with average TAC-AUC during the pre-CM period, though higher self-reported alcohol use over the preceding 30 days was significantly associated with higher baseline connectivity within the Dorsal Attention Network (DAN; p-FDR &lt; 0.05). Baseline connectivity within the Salience network was significantly negatively related to objective drinking reduction after intervention (DAN; p-FDR &lt; 0.05), whereas baseline connectivity within the Limbic network was positively associated with self-reported drinking reduction (p-FDR &lt; 0.05). Change in between-networks functional connectivity after intervention was significantly positively associated with biosensor-confirmed drinking reduction such that higher reduction was associated with stronger connectivity between the limbic and fronto-parietal control networks (p-FDR &lt; 0.05). PLWH with lower DAN connectivity at baseline demonstrated poorer alcohol reduction than those with higher DAN connectivity at baseline.</p>
        </sec>
        <sec>
          <title>Discussion</title>
          <p>Lower resting-state functional connectivity of the Salience network significantly predicted stronger drinking reduction across all participants, suggesting a potential biomarker for reduced susceptibility to the environmental and social cues that often make alcohol use reduction attempts unsuccessful. Increased between-networks connectivity was observed in participants with higher alcohol reduction after CM, suggesting a positive benefit to brain connectivity associated with reduced drinking. PLWH with lower baseline DAN connectivity may not benefit as greatly from CM for alcohol reduction.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>human immunodeficiency virus</kwd>
        <kwd>alcohol use</kwd>
        <kwd>resting-state functional magnetic resonance imaging</kwd>
        <kwd>contingency management</kwd>
        <kwd>cessation</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="1"/>
        <equation-count count="2"/>
        <ref-count count="89"/>
        <page-count count="13"/>
        <word-count count="10975"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>section-at-acceptance</meta-name>
          <meta-value>Addictive Disorders</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec5">
      <title>Background</title>
      <p>People living with human immunodeficiency virus (PLWH) demonstrate a 29.8% point-prevalence of alcohol use disorder (AUD) (<xref rid="ref1" ref-type="bibr">1</xref>), which is considerably high given the implications heavy alcohol use has on the immune system (<xref rid="ref2" ref-type="bibr">2</xref>) and on the metabolism of antiretroviral drugs (<xref rid="ref3" ref-type="bibr">3</xref>) in this population. Not only has heavy alcohol use been associated with increased risk of all-cause mortality among PLWH compared to those without HIV (<xref rid="ref4" ref-type="bibr">4</xref>), its impact is widespread across domains of health, social, cognitive, and brain functioning (<xref rid="ref5" ref-type="bibr">5–11</xref>). In fact, heavy alcohol use has been shown to have more deleterious effects on cognitive and neural domains in PLWH when compared to people without HIV (<xref rid="ref12" ref-type="bibr">12</xref>). Specifically of interest is the effect of these comorbid conditions on neural functioning, where our group has demonstrated a number of effects of heavy alcohol use in HIV including reduced frontal white matter integrity (<xref rid="ref13" ref-type="bibr">13</xref>) and reduced functional connectivity of frontal and parietal attentional networks (<xref rid="ref14" ref-type="bibr">14</xref>). Despite the risk factors associated with heavy drinking, studies of drinking cessation and its effects on brain function in PLWH are quite limited, thus necessitating further work to highlight the clinical relevance of functional connectivity changes in drinking cessation among people living with and without HIV.</p>
      <sec id="sec6">
        <title>Introduction to neural networks under study</title>
        <p>Neural networks in the brain are large-scale functional and structural networks composed of groups of interconnected neurons and brain regions that work together to process and integrate information. Some of the most commonly examined resting-state networks in the context of alcohol use and HIV include the default mode network (DMN), the dorsal attention network (DAN), the cingulo-opercular network (CON/Salience network), the limbic network, and the fronto-parietal control network (FPCN). The DMN comprises regions including the medial prefrontal cortex, posterior cingulate cortex, and the inferior parietal lobule and is active when an individual is at rest, suggesting involvement in intrinsic activity. The DMN is also thought to play a role in regulating attention and monitoring the external environment for salient information (<xref rid="ref15" ref-type="bibr">15</xref>). The DAN includes several regions of the parietal and frontal cortices, including the superior parietal lobule, intraparietal sulcus, and frontal eye fields, and has been implicated in controlling attention and selecting relevant information from sensory input. It is primarily responsible for directing attention to visual and spatial information, and for the control of voluntary eye movements (<xref rid="ref16" ref-type="bibr">16</xref>). The cingulo-opercular (e.g., salience) network is a neural network in the brain that is involved in detecting and filtering important or salient sensory and cognitive information from the environment or internal mental states. It includes the anterior insula, dorsal anterior cingulate cortex (dACC), and the fronto-insular cortex (<xref rid="ref17" ref-type="bibr">17</xref>). The limbic network is a group of interconnected brain structures (e.g., the hippocampus, amygdala, hypothalamus, thalamus, and cingulate gyrus) that play a key role in emotional processing, motivation, learning, and memory (<xref rid="ref18" ref-type="bibr">18</xref>). The FPCN is involved in cognitive control, attentional processing, working memory, planning, goal-directed behavior, and decision-making, and consists of regions in the prefrontal and parietal cortices that are interconnected by white matter tracts, enabling the rapid transmission of information between these regions (<xref rid="ref19" ref-type="bibr">19</xref>). There is an abundance of evidence suggesting alterations in the resting-state functional connectivity (rsFC) of these neural circuits associated with AUD and HIV.</p>
      </sec>
      <sec id="sec7">
        <title>Functional connectivity in AUD</title>
        <p>AUD is thought to be caused by a compulsive “drive” toward alcohol consumption (<xref rid="ref20" ref-type="bibr">20</xref>) as well as an inability to inhibit alcohol consumption, which correspond with increased activity in the appetitive drive networks (a subset of the limbic network associated with reward processing) and decreased activity in brain regions which mediate executive control compared to individuals without AUD (<xref rid="ref21" ref-type="bibr">21–23</xref>). Resting-state fMRI research in alcohol use and disorders consistently implicates the DMN, the FPCN (also referred to as the Central Executive Network), and the salience network (<xref rid="ref20" ref-type="bibr">20</xref>). For example, one group found that alcohol use disorder was associated with increased connectivity between fronto-parietal regions involved in cognitive control and decreased connectivity between nine regions of the Salience network involved in reward processing and emotional regulation (Kamarajan, 2022). Similarly, increased between-network rsFC among the executive control network, Salience network, and Limbic regions including the striatum and amygdala as well as increased within-network connectivity in the Salience network, DMN, executive control network, and Limbic network has been found in individuals with AUD (Le Berre et al. 2017). Additionally, rsfMRI studies have shown decreased synchronicity in the posterior cingulate and cerebellar regions (i.e., circuitry of the DMN and DAN) in people with AUD, indicating compromised functional connectivity (<xref rid="ref28" ref-type="bibr">28</xref>). These rsFC differences may contribute to the cognitive and emotional deficits commonly observed in individuals with chronic alcohol use. However, these alterations in activation may be reversible after prolonged reduction in alcohol use.</p>
      </sec>
      <sec id="sec8">
        <title>Connectivity changes after drinking reduction</title>
        <p>Following drinking reduction and abstinence, individuals with AUD experience altered neural circuits of stress and reward modulation (e.g., increased limbic network circuitry), making them highly sensitive to stress, anxiety, low mood, autonomic nervous system disruption, fatigue, and sleep problems (<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref30" ref-type="bibr">30</xref>). Functional MRI (fMRI) studies have shown that participants with AUD who stop drinking demonstrate greater activity in limbic-striatal regions (e.g., the limbic network) associated with emotional processing and lower activity in the medial frontal and cingulate regions, particularly in the caudate and posterior cingulate regions associated with emotional regulation, self-control, and executive functioning (<xref rid="ref31" ref-type="bibr">31–33</xref>). These findings either suggest negative implications of drinking reduction in this population, specifically increased emotional reactivity and decreased self-monitoring, which may make it more difficult to maintain abstinence, or indicate a lack of reversibility of functional connectivity changes associated with AUD. Interestingly, individuals with alcohol use disorders who successfully completed detoxification showed higher connectivity of the DMN, the FPCN, and the salience network compared to those who dropped out of treatment (<xref rid="ref34" ref-type="bibr">34</xref>). However, several studies have identified evidence for compensatory mechanisms in the resting state networks of long-term abstinent individuals with AUD. One study found increased synchrony in the inhibitory control network (i.e., a subset of the FPCN) and reduced synchrony in the appetitive drive reward network in long-term abstinent persons with AUD when compared to controls without AUD (J. Camchong, Stenger, and Fein 2013), suggesting alterations in connectivity with prolonged drinking reduction. Similarly, Chanraud et al (2011) found resting state synchronicity in posterior cingulate and cerebellar regions (i.e., circuitry of the DMN and DAN) in abstinent persons with AUD compared to age-matched healthy controls who did not meet criteria for AUD connectivity that improved with longer durations of abstinence (Chanraud et al. 2011). Similarly, another study found increased synchrony in the inhibitory control network (i.e., a subset of the FPCN) and reduced synchrony in the appetitive drive reward network in long-term abstinent persons with AUD when compared to controls without AUD (<xref rid="ref35" ref-type="bibr">35</xref>), suggesting alterations in connectivity with prolonged drinking reduction. While there is evidence for neurobiological changes following drinking reduction and abstinence in adults with AUD, the length of abstinence needed to achieve these changes is unknown. Similarly, there is a dearth of literature investigating these effects in PLWH.</p>
      </sec>
      <sec id="sec9">
        <title>Connectivity in PLWH</title>
        <p>fMRI techniques have been widely used to investigate the neural basis of HIV-associated neurocognitive disorders. In fact, previous fMRI studies have demonstrated marked functional connectivity differences in PLWH, independent of alcohol consumption. For example, a recent meta-analysis found consistent alterations in the fronto-striatal-parietal sub-networks (functionally related to the FPCN), including hyperactivation in the left inferior frontal gyrus and caudate nucleus, which are associated with cognitive impairment, disease progression, and treatment outcomes (<xref rid="ref36" ref-type="bibr">36</xref>). Further, reduced within-network connectivity of the DMN, the FPCN, and the salience network is implicated in PLWH, in addition to inter-network differences in the DAN and the salience network (<xref rid="ref37" ref-type="bibr">37</xref>). In studies utilizing diffusion tensor imaging (DTI), duration of HIV infection has been independently associated with white matter injury, especially in frontal projections of the corpus callosum and thalamus (<xref rid="ref38" ref-type="bibr">38</xref>). Importantly, fronto-striatal and fronto-parietal circuits implicated in HIV progression are functionally involved in the inhibition and regulation of appetitive, attention, impulsive, and emotional responses and behaviors (<xref rid="ref39" ref-type="bibr">39</xref>), and therefore may be altered by substance abuse. Indeed, in a prior rsfMRI study, our group has shown in a prior resting-state fMRI study lower fronto-parietal connectivity (e.g., FPCN) and increased connectivity between attention/working memory networks (i.e., the DAN) and mesolimbic regions (i.e., the limbic network) critical to addiction in PLWH with chronic alcohol abuse (<xref rid="ref14" ref-type="bibr">14</xref>). Taken together, previous research indicates reduced white matter integrity in regions important for inhibition and regulation of alcohol consumption as well as increased connectivity between regions implicated in appetitive drive toward alcohol consumption, suggesting a compounding of effects in individuals with HIV and alcohol use disorder.</p>
      </sec>
      <sec id="sec10">
        <title>Alcohol monitoring and interventions</title>
        <p>Behavioral interventions focusing on reducing the frequency of harmful alcohol use are becoming increasingly common. Contingency management (CM) is one of the most effective evidence-based treatment approaches directly addressing substance use disorder that encourages drinkers to alter their drinking behavior to reduce the probability of alcohol-related consequences (<xref rid="ref40" ref-type="bibr">40</xref>, <xref rid="ref41" ref-type="bibr">41</xref>). CM is a behavioral treatment based on operant conditioning principles that gives participants rewards in the form of cash, prizes, or vouchers to reinforce positive behaviors, such as alcohol abstinence (<xref rid="ref42" ref-type="bibr">42</xref>). This operant conditioning approach is often preferred by patients and their clinicians (<xref rid="ref43" ref-type="bibr">43</xref>, <xref rid="ref44" ref-type="bibr">44</xref>), and contingency management as a harm-reduction intervention produces similar health outcomes as those who abstain from alcohol (<xref rid="ref45" ref-type="bibr">45</xref>, <xref rid="ref46" ref-type="bibr">46</xref>).</p>
        <p>Technologies that allow continuous monitoring of alcohol use have been developed and combined with the CM approach to objectively monitor drinking reduction, such as transdermal alcohol detection. This method senses the 1% of ingested alcohol that is secreted through the skin via sweat glands and diffusion (<xref rid="ref47" ref-type="bibr">47</xref>), allowing for the separation of heavy drinking episodes from lower and moderate drinking levels (<xref rid="ref48" ref-type="bibr">48</xref>, <xref rid="ref49" ref-type="bibr">49</xref>). One device, the Secure Continuous Remote Alcohol Monitoring bracelet (SCRAM, Alcohol Monitoring Systems; AMS), which is regularly worn by court-referred offenders, has been established as valid in controlled laboratory and field trials (<xref rid="ref50" ref-type="bibr">50</xref>, <xref rid="ref51" ref-type="bibr">51</xref>). This device contains three sensors that assess contact with the skin, skin temperature, and perspiration once every 30 min. As a noninvasive measurement approach, the SCRAM measures the concentration of alcohol in insensible perspiration, providing estimates of the frequency and quantity of alcohol consumption over extended periods of time within the participant’s natural environment while avoiding the limitations of frequent testing and self-report.</p>
        <p>Transdermal alcohol detection devices, such as the SCRAM, have shown a strong correlation (<italic>r</italic> = 0.84) between area under the curve (AUC) values and breath alcohol content (BrAC) (<xref rid="ref51" ref-type="bibr">51</xref>). The SCRAM-CAM (Secure Continuous Remote Alcohol Monitor Continuous Alcohol Monitoring; Alcohol Monitoring Systems, Inc., Littleton, CO) anklet is the most commonly used and well-validated alcohol biosensor available (<xref rid="ref52" ref-type="bibr">52–54</xref>). The SCRAM device can reflect blood alcohol concentration (BAC) within a drinking event continuously and in near real-time (<xref rid="ref55" ref-type="bibr">55</xref>) by plotting the transdermal alcohol content (TAC) curve, as well as the AUC value representing the geometric area beneath the TAC curve (<xref rid="ref56" ref-type="bibr">56</xref>). Peak TAC represents the highest level of TAC reached during a drinking episode (<xref rid="ref48" ref-type="bibr">48</xref>), while area under the curve (TAC-AUC) represents an individual’s total exposure to alcohol during a drinking episode (<xref rid="ref57" ref-type="bibr">57</xref>). Studies report that TAC is significantly associated with self-reported drinking with correlations ranging from 0.30 to 0.74 (<xref rid="ref58" ref-type="bibr">58–61</xref>). In a laboratory setting, peak TAC and TAC-AUC have strong correlations to breath alcohol concentration (0.6–0.9) (<xref rid="ref51" ref-type="bibr">51</xref>). However, SCRAM data, much like BrAC, cannot yet be directly equated into number of drinks consumed. Thus, the equivocation of SCRAM data to real-life drinking level in cross-sectional research is limited, and within-subjects, longitudinal data analysis may be more appropriate.</p>
        <p>In the present study, we sought to determine: (1) the baseline associations between resting-state functional MRI (rsfMRI) connectivity, self-reported and objective alcohol use, and HIV, (2) changes in rsfMRI connectivity after 30 days of attempted abstinence from heavy alcohol use (including reduction of alcohol use), and (3) how rsfMRI connectivity alterations after 30 days attempted abstinence from heavy alcohol use differ between PLWH and people without HIV. We propose the examination of five resting-state networks (DMN, DAN, CON/Salience, limbic, and FPCN) in the present study examining the effects of alcohol reduction in individuals exhibiting current heavy alcohol use who may or may not carry a diagnosis of HIV. Prior to data analysis, we hypothesized that participants living with HIV will demonstrate lower rsfMRI connectivity within regions comprising frontal networks, including the Fronto-Parietal Control Network (FPCN), Default Mode Network (DMN), and Limbic, but will be equivalent to participants without HIV in remaining resting-state network (CON/Salience). Further, we hypothesized that resting-state connectivity will be negatively associated with self-reported drinking severity at baseline (prior to intervention), and that associations between resting-state connectivity and drinking severity will be enhanced in participants living with HIV compared to participants without HIV. With regard to changes after the intervention, we hypothesized that participants with stronger abstinence as measured by lower self-reported drinking and a lower TAC-AUC over the 30-day period will demonstrate enhanced rsfMRI connectivity across FPCN, DMN, and Limbic networks. We also hypothesized that participant HIV status will serve to enhance connectivity improvements associated with abstinence, such that those with HIV will see larger relative connectivity changes compared to baseline.</p>
      </sec>
    </sec>
    <sec sec-type="methods" id="sec11">
      <title>Methods</title>
      <sec id="sec12">
        <title>Participants</title>
        <p>Participants were part of the 30-Day Challenge study, which is a study to test the effects of alcohol reduction through CM in older adults with heavy alcohol use living with or without HIV who are interested in reducing their alcohol intake. All in-person procedures were conducted at either the University of Miami or Florida International University. To be eligible, participants had to be between 45 and 75 years old, living with or without HIV (confirmed via medical record, medication, or blood test); drink heavily (≥14 drinks/week for women, ≥21 drinks/week for men) in the past 30 days; speak English; be willing to participate in CM to reduce their alcohol use; and be willing to wear the SCRAM for at least 30 days. Participants may have been in treatment for alcohol use in the past, but must not have been actively enrolled in another treatment program or research study at the time of their participation. A total of 39 participants completed MRI at both the baseline and 30-day time points. Of these, one subject was removed due to corrupt rsfMRI data, one was removed for rsfMRI global signal change greater than 3SD from the group mean, and two were removed for rsfMRI motion parameters exceeding 3SD of the group mean, resulting in a final sample of 35 participants. Of the 35 participants in the study, 18 were living with HIV and 17 were people without HIV.</p>
      </sec>
      <sec id="sec13">
        <title>Objective alcohol use monitoring</title>
        <p>As described in our group’s previous work (<xref rid="ref60" ref-type="bibr">60</xref>), after providing consent participants were entered into an enrollment eligibility phase in which they would wear the SCRAM biosensor for a pre-contingency management (pre-CM) “test week” (hereafter referred to as the Pre-CM period) during which they provided self-reported drinking information. The purpose of the pre-CM period was to confirm that the participant did meet heavy drinking criteria, that they could tolerate the SCRAM monitor, and to demonstrate that the monitor accurately detected drinking days prior to participants entering a CM period. The SCRAM monitor was installed on the participant’s preferred leg and locked in placed once the participant was ready to leave the lab. The participant was given instructions about the monitor, including not to submerge the device in water, to avoid using alcohol-based items (e.g., perfume, bug spray), and not to wear socks under the monitor. Participants were instructed to drink as they normally would during the pre-CM period for all but 1 day of their choosing, in which a day of abstinence was required to assure that the monitor could accurately distinguish between drinking days and abstaining days. During the Pre-CM period, a research assistant called the participant at the end of the week and collected information about self-reported drinking, including the number of drinks on each drinking day. When the participants returned at the end of the pre-CM period, the data on the ankle monitor were uploaded to the SCRAM system using the DirectConnect device. As detailed in a recent work by our group, “TAC data were collected by the SCRAM-CAM and transmitted to the AMS server using the company’s DirectConnect device. Data were downloaded from the server through a password-protected portal. The Transdermal Alcohol Sensor Data Macro (TASMAC Software) read and interpreted data from the SCRAM” (<xref rid="ref62" ref-type="bibr">62</xref>). The participant took the DirectConnect device home so that the research assistant could check their daily data. The daily compensation was calculated based on their daily data using the social day from 6:00 am to 6:00 am.</p>
      </sec>
      <sec id="sec14">
        <title>Intervention: contingency management</title>
        <p>Contingency management (CM) was implemented in the present study after the pre-CM period through direct payment for alcohol abstinence. Abstinence was determined on a daily basis through remote monitoring (SCRAM) with distribution of funds to the participant upon confirmation of abstinence by a team member. After the pre-CM period, the participant completed a baseline assessment that included neuropsychological testing, additional questionnaires, and blood testing. Subsequently, participants began the 30-day enrollment “challenge” period during which continuous monitoring of alcohol use was enacted using the SCRAM device. At the conclusion of the 30-day CM period, participants again completed all measures from the baseline assessment listed above.</p>
        <p>Payments: On the first day of sobriety, a participant would receive $5. For each consecutive day after their payout, it would increase by $1 (e.g., on day one, participants receive $5, day two participant receives $6, etc.) at day seven, they can receive a total of $45 plus a bonus of $25 for maintaining abstinence for seven consecutive days. The bonus payments increase by $20 every 7 days. Therefore, at 14 days of abstinence, their bonus would be $40. The max amount paid for maintaining abstinence throughout a challenge (30 days) could be a total of $440 (not including payout for assessment visits), and a minimum payout could be $0 if the participant had a drinking episode every day. As for the payouts, the participants often chose to receive payments every 8 days (after earning a bonus) to take advantage of the lump sum of money earned for maintaining abstinence. During enrollment, participants were asked about their preferred method of funds transfer and frequency of payments to collect for adjustments and bonuses.</p>
      </sec>
      <sec id="sec15">
        <title>Analysis of subjective alcohol use</title>
        <p>The timeline follow-back (TLFB) is a self-report measure of alcohol consumption over the past 30 days which is typically used to calculate the average number of drinks per day over the prior month (<xref rid="ref63" ref-type="bibr">63</xref>). The process involves asking participants to recount their drinking behaviors in terms of number of drinks as a team member moves across a calendar, referencing anchors and reminders (e.g., holidays) about what a participant did each day to assist with memory. For the purposes of this study, 30-day timeline follow-back was completed with each participant at the baseline timepoint and the 30-day follow-up timepoint. The average number of drinks per day was then calculated by dividing their total reported number of drinks by a constant of 30. This provided a TLFB-30 data point at the baseline visit as well as at the 30-day follow-up visit. Lastly, a percent reduction value was calculated from these data such that their post-intervention 30-day TLFB total was subtracted from the pre-intervention 30-day TLFB total and divided by the pre-intervention total.<disp-formula id="E1">
<mml:math id="M1" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi>T</mml:mi><mml:mi>L</mml:mi><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mo>−</mml:mo><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi>T</mml:mi><mml:mi>L</mml:mi><mml:mi>F</mml:mi><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi>T</mml:mi><mml:mi>L</mml:mi><mml:mi>F</mml:mi><mml:mi>B</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math>
</disp-formula></p>
      </sec>
      <sec id="sec16">
        <title>Analysis of objective alcohol use monitoring</title>
        <p>The Transdermal Alcohol Sensor Data Macro (TASMAC Software) (<xref rid="ref64" ref-type="bibr">64</xref>) was utilized to read and interpret data from the SCRAM biosensor. The TASMAC integrates previously published criteria designed to be more sensitive than the default SCRAM criteria (established by the AMS Inc.) to detect drinking episodes (<xref rid="ref65" ref-type="bibr">65</xref>). The present study used TAC-AUC generated by the TASMAC as the primary estimate of average daily alcohol use over the test week and 30-day test period. Specifically, daily TAC-AUC was calculated as the sum of all TAC-AUC from detected drinking episodes that began on the SCRAM-detected drinking day. If there were multiple drinking episodes within a single drinking day, TAC-AUCs were summed. For the purposes of analysis, three variables were computed, including (1) the TAC-AUC average over the seven drinking days prior to the intervention, (2) TAC-AUC average over the final 7 days of the 30-day intervention period, and (3) the percent reduction from pre- to post-intervention calculated through the formula:<disp-formula id="E2">
<mml:math id="M2" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width="thickmathspace"/><mml:mi>T</mml:mi><mml:mi>A</mml:mi><mml:mi>C</mml:mi><mml:mo>_</mml:mo><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>C</mml:mi><mml:mo>−</mml:mo><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width="thickmathspace"/><mml:mi>T</mml:mi><mml:mi>A</mml:mi><mml:mi>C</mml:mi><mml:mo>_</mml:mo><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width="thickmathspace"/><mml:mi>T</mml:mi><mml:mi>A</mml:mi><mml:mi>C</mml:mi><mml:mo>_</mml:mo><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math>
</disp-formula></p>
        <p>The rationale for the use of the TAC-AUC during the final 7 days of the 30-day intervention is that doing so creates a time point most proximal to the acquisition of neuroimaging and equivocal both in duration and proximity to the neuroimaging as the pre-CM TAC-AUC data.</p>
        <p><italic>Specific abstinence calculation procedure</italic>: To determine whether the participant remained abstinent based on objective SCRAM data, we used sensitive criteria originally devised by Barnett et al., as follows:<list list-type="order"><list-item><p>The peak of TAC data must reach = &gt; 0.02 at least once (basic criteria).</p><p>and</p></list-item><list-item><p>Absorption rate must be less than 0.05.</p><p>or</p></list-item><list-item><p>For a peak &lt;=0.15, elimination rate must be (&gt;0.003 and &lt; 0.025).</p></list-item></list></p>
        <p>For a peak &gt;0.15, elimination rate must be (&gt;0.003 and &lt; 0.035).</p>
        <p>A drinking episode must meet rule 1 and 2 (based on absorption rate) OR rule 1 and 3 (based on elimination rate). TAC data that do not meet these criteria are not considered to be true drinking episodes and will be ignored. This macro evaluates days based on a 24-h “social day” from 6 AM to 6 AM.</p>
      </sec>
      <sec id="sec17">
        <title>Magnetic resonance imaging</title>
        <p>Participants completed a 1-h MRI acquisition on a Siemens Skyra 3 T MRI scanner (Siemens Medical Solutions, Erlangen, Germany) at the University of Miami. The 3D T1 weighted volumetric magnetization-prepared rapid gradient-echo sequence (MP-RAGE) consisted of 176 slices at slice thickness = 1 mm isotropic, FOV = 256×256, TR = 1.80s, and TE = 2.67 s. The resting-state functional MRI (rsfMRI) scan was administered for 8 min with eyes open consisting of 120 volumes and 48 interleaved slices at a slice thickness = 3.0 mm isotropic, FOV = 212×212, TR = 3.0 s, and TE = 30 ms.</p>
      </sec>
      <sec id="sec18">
        <title>Functional MRI pre-processing</title>
        <p>Functional MRI pre-processing was completed in accordance with past studies by our group (<xref rid="ref66" ref-type="bibr">66</xref>). Specifically, functional images were preprocessed and analyzed using the MATLAB R2016b based functional connectivity toolbox “Conn toolbox” version 19c and SPM 12 (<xref rid="ref67" ref-type="bibr">67</xref>, <xref rid="ref68" ref-type="bibr">68</xref>). We followed a pre-processing pipeline which included functional realignment and unwarping, functional centering of the image to (0, 0, 0) coordinates, slice-timing correction, structural centering to (0, 0, 0) coordinates, structural segmentation and normalization to MNI space, functional normalization to MNI space, and spatial smoothing with a kernel of 8 mm FWHM. During pre-processing, the Conn toolbox implements an anatomical, component-based, noise correction strategy (aCompCor) for spatial and temporal processing to remove physiological noise factors from the data (<xref rid="ref69" ref-type="bibr">69</xref>). The implementation of aCompCor combined with the quantification of participant motion and the identification of outlier scans through the Artifact Rejection Toolbox (ART) allows for better interpretation of functional connectivity results (<xref rid="ref68" ref-type="bibr">68–70</xref>). The ART was set to the 97th percentile setting with the mean global-signal deviation threshold set at <italic>z</italic> = ±3 and the participant-motion threshold set at 0.9 mm. As mentioned above, participants were removed if (1) global signal change was greater than 3SD from the group mean (one participant removed), (2) motion parameters exceeding 0.9 mm (two participants removed), and (3) number of invalid scans exceeding 20% of total scans (no participants removed). Applying linear regression and using a band-pass filter of 0.008–0.09 Hz, data were de-noised to exclude signal frequencies outside of the range of expected BOLD signals (such as low-frequency scanner drift), minimize participant motion, extract white matter and cerebral spinal fluid noise components, and control for within-participant realignment and scrubbing covariates.</p>
      </sec>
      <sec id="sec19">
        <title>Within- and between-networks analysis of rsfMRI connectivity</title>
        <p>For statistical analysis of rsfMRI connectivity, we used a publicly available network parcellation of the brain (<xref rid="ref71" ref-type="bibr">71</xref>) that has been commonly used in the resting-state literature (<xref rid="ref72" ref-type="bibr">72–79</xref>). From this atlas, we utilized five main networks to include: (1) the Cingulo-Opercular Network (consisting of the parietal operculum, temporal occipital cortex, frontal operculum, lateral prefrontal cortex); (2) Default Mode Network (prefrontal cortex, posterior cingulate cortex, parahippocampal cortex, and parietal and temporal cortices [corresponding to the angular gyrus and middle temporal gyrus, posterior division, respectively]), (3) the Dorsal Attention Network (posterior cortex [corresponding to the lateral occipital cortex, superior division], frontal eye fields, and precentral ventral cortex), (4) the Fronto-Parietal Control Network (parietal cortex [corresponding to the posterior division of the supramarginal gyrus], temporal cortex [corresponding to the posterior division of the middle temporal gyrus], dorsal prefrontal cortex, lateral prefrontal cortex, orbitofrontal cortex, ventral prefrontal cortex, medial posterior prefrontal cortex, precuneus, and the cingulate cortex), and (5) the Limbic Network (orbitofrontal cortex [corresponding to the frontal pole], temporal pole). The resting-state networks were registered to MNI152 space, and we defined the networks as regions of interests (ROIs) for ROI-ROI functional connectivity analyses. ROI-ROI analyses are Fisher z-transformed bivariate correlations between brain regions’ BOLD time-series that quantify associations in the activation at rest and serve as a proxy for functional connectivity. Using the Conn toolbox Results Explorer, within-network connectivity was calculated and compared with one or more variables of interest by computing the mean of the pairwise correlations between the specified ROIs that comprised each of the five higher-order functional networks. Between-networks connectivity comparisons were computed using the Conn Toolbox ROI-to-ROI approach, such that a seed’s BOLD time course signal is used as a reference for correlations followed via a search for any correlation with other ROIs’ positive and negative BOLD time course signal. Manual error correction settings were utilized such that all analyses were corrected for false discovery rate (FDR) at the connection level (p-FDR &lt; 0.05) and at the cluster level with an MVPA omnibus test (p-FDR &lt; 0.05).</p>
      </sec>
      <sec id="sec20">
        <title>Statistical approach</title>
        <p>PLWH and people without HIV were compared on demographic variables and alcohol use characteristics (both TLFB and TAC-AUC data) with <italic>t</italic>-test or Chi-square analysis, where appropriate. Variables where significant differences exist were inputted as covariates in any rsfMRI analyses comparing groups. Correlational analyses were completed to determine the relationship between all other measures were analyzed for normality and fit, with appropriate normalization applied where necessary.</p>
      </sec>
      <sec id="sec21">
        <title>HIV status, within-network rsfMRI connectivity, and alcohol use: interactive associations</title>
        <p>Statistical analyses were deployed to examine the effect of HIV status on connectivity at the pre- and post-CM periods as well as connectivity change as a function of self-reported and objective alcohol use (TAC-AUC) reduction. Connectivity values for each network at baseline, 30-day follow-up, and change from baseline to follow-up were centered by demeaning each participant’s connectivity value. An interaction term was then created between centered connectivity values and HIV status. Given the fact that baseline characteristics may influence later outcomes related to interventions, such as CM, HIV status, the centered connectivity values, and the interaction term were then entered into a linear regression equation predicting either TAC-AUC percent reduction or TLFB percent reduction. All assumptions for normality were met through examination of the P–P plots for potential heteroscedasticity. For interaction analyses, the direction for the overall model equation was computed for each group to confirm association slopes were opposing, as is often the case when an regression interaction is present.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="sec22">
      <title>Results</title>
      <p>The majority of participants were male (60%), identified as Black (74.3%) non-Hispanic (85.7%). Participants did not differ on demographic variables when comparing groups by HIV status (<xref rid="tab1" ref-type="table">Table 1</xref>). PLWH did not differ from those living without HIV on any rsfMRI QC metrics related to motion, global signal change, or number of invalid scans.</p>
      <table-wrap position="float" id="tab1">
        <label>Table 1</label>
        <caption>
          <p>Demographics.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" valign="top" rowspan="1" colspan="1">Variable</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Total <italic>N</italic> = 35</th>
              <th align="left" valign="top" rowspan="1" colspan="1">PLWH <italic>N</italic> = 18</th>
              <th align="left" valign="top" rowspan="1" colspan="1">w/out HIV <italic>N</italic> = 17</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Age (mean ± stdev)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">57.2 ± 4.6</td>
              <td align="center" valign="top" rowspan="1" colspan="1">55.6 ± 3.9</td>
              <td align="center" valign="top" rowspan="1" colspan="1">57.9 ± 5.3</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="4" rowspan="1">Current gender identity (%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Male</td>
              <td align="center" valign="top" rowspan="1" colspan="1">60.0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">55.6%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">64.7%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Female</td>
              <td align="center" valign="top" rowspan="1" colspan="1">37.1%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">38.9%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">35.3%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Transgender</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2.9%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">5.6%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="4" rowspan="1">Race (%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Caucasian</td>
              <td align="center" valign="top" rowspan="1" colspan="1">20.0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">22.2%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">17.6%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Black</td>
              <td align="center" valign="top" rowspan="1" colspan="1">74.3%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">77.8%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">70.6%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">American Indian/Alaska Native</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Native Hawaiian/Pacific Islander</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Asian</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Multi-racial</td>
              <td align="center" valign="top" rowspan="1" colspan="1">5.7%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">11.8%</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="4" rowspan="1">Ethnicity (%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Hispanic</td>
              <td align="center" valign="top" rowspan="1" colspan="1">14.3%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">11.1%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">17.6%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Non-Hispanic</td>
              <td align="center" valign="top" rowspan="1" colspan="1">85.7%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">88.9%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">82.4%</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="4" rowspan="1">Education level (%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Did not finish high school</td>
              <td align="center" valign="top" rowspan="1" colspan="1">28.6%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">33.3%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">23.5%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">High school</td>
              <td align="center" valign="top" rowspan="1" colspan="1">34.3%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">22.2%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">47.1%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Greater than high school</td>
              <td align="center" valign="top" rowspan="1" colspan="1">37.1%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">44.4%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">29.4%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">HIV disease duration (years)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
              <td align="center" valign="top" rowspan="1" colspan="1">18.82 (12.4)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Viral load (≥40 copies/mL)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.24 (0.44)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">CD4 Count (cells/μL)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
              <td align="center" valign="top" rowspan="1" colspan="1">600.28 (345.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Currently taking HIV antiretroviral medication</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
              <td align="center" valign="top" rowspan="1" colspan="1">100%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">–</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Ever diagnosed with AIDS</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">22.2%</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Years since first regular alcohol use<sup>a</sup></td>
              <td align="center" valign="top" rowspan="1" colspan="1">37.74 (7.80)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">36.44 (6.75)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">39.12 (8.78)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">TLFB-30 pre-CM (mean ± stdev)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">8.44 (3.99)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">8.53 (4.50)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">8.35 (3.50)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">TLFB-30 post-CM (mean ± stdev)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.76 (1.62)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.23 (2.14)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.27 (0.44)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">TLFB-30 percent reduction (mean ± stdev)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">89.4% (20.1)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">82.9% (26.2)*</td>
              <td align="center" valign="top" rowspan="1" colspan="1">96.3% (6.1)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">TAC-AUC pre-CM (mean ± stdev)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">27.50 (27.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">24.51 (28.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">30.67 (26.9)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">TAC-AUC post-CM (mean ± stdev)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">6.16 (13.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">5.95 (14.1)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">6.39 (12.6)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">TAC-AUC percent reduction (mean ± stdev)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">60.5% (93.3)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">45.5% (114.3)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">75.5% (66.7)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>*PLWH and people without HIV differ (<italic>p</italic> &lt; 0.05); <sup>a</sup>Defined as using alcohol at least once per week.</p>
          <p>TLFB, Timeline Follow-Back 30; TAC-AUC, transdermal alcohol content (TAC) area under the curve; TLFB pre-CM, the reported daily average number of drinks over the 30 days prior to contingency management; TLFB post-CM, the reported daily average number of drinks over the 30 days of contingency management; TAC-AUC pre-CM, average daily AUC over the 7 days prior to contingency management; TAC-AUC post-CM, average daily AUC over the final 7 days of the contingency management period; Percent Reduction = [(Baseline – Follow-up) / Baseline]*100.</p>
        </table-wrap-foot>
      </table-wrap>
      <sec id="sec23">
        <title>Pre- and post-contingency management alcohol consumption</title>
        <p>On the pre-CM TLFB-30, participants reported a mean of 253.3 (SD = 119.7) standard drinks consumed, or 8.44 drinks per day (SD = 3.99), on average. During the 7 days leading up to the intervention, the average daily TAC-AUC was 27.5 h · g/dl (SD = 27.2). Over the 30 days of intervention, participants self-reported an average of 22.8 (SD = 48.6) drinks on the TLFB-30, or 0.76 drinks per day (SD = 1.62). During the final 7 days of the 30-day intervention, the average daily TAC-AUC was 6.16 h · g/dl (SD = 13.2). In terms of percent reduction in alcohol consumption, results indicate an 89.4% reduction in average daily self-reported alcohol use on the TLFB-30 and a 60.5% reduction in average daily objective alcohol use on TAC-AUC (<xref rid="tab1" ref-type="table">Table 1</xref>).</p>
      </sec>
      <sec id="sec24">
        <title>Baseline functional connectivity</title>
        <p>Average TAC-AUC for objective drinking over the 7 days prior to the intervention was not significantly associated with functional connectivity at baseline after correction for false discovery rate (FDR). Baseline functional connectivity within two bilateral nodes of the DAN was positively associated with higher self-reported (TLFB) pre-CM drinking over the seven days immediately before the MRI session (F[1,33] = 24.96, p-unc = 0.000019, p-FDR = 0.00012); an association occurring in the opposite direction of our initial hypothesis (<xref rid="fig1" ref-type="fig">Figure 1A</xref>).</p>
        <fig position="float" id="fig1">
          <label>Figure 1</label>
          <caption>
            <p><bold>(A)</bold> Within-networks baseline rsfMRI and subjective pre-intervention drinking (p-FDR = 0.0001), <bold>(B)</bold> within-networks baseline rsfMRI and predicted 30-day subjective percent drinking reduction (p-FDR = 0.046), <bold>(C)</bold> within-networks 30-day rsfMRI and predicted 30-day subjective percent drinking reduction, <bold>(D)</bold> within-networks baseline rsfMRI and objective drinking reduction (p-FDR = 0.039), <bold>(E)</bold> between-networks pre-post rsfMRI change and objective drinking reduction. Blue line, positive association between connectivity and drinking reduction; Red line, negative association between connectivity and drinking reduction; CON, Cingulo-Opercular Network; DAN, Dorsal Attention Network; DMN, Default Mode Network; FPCN, Fronto-Parietal Control Network; LH, Left Hemisphere; RH, Right Hemisphere.</p>
          </caption>
          <graphic xlink:href="fpsyt-14-1102368-g001" position="float"/>
        </fig>
        <p>Baseline functional connectivity between multiple nodes within the CON was negatively associated with TAC-AUC reduction after CM (Cluster 1: F[2,29] = 5.86, p-unc = 0.007303, p-FDR = 0.038744; Cluster 2: F[2,29] = 5.77, p-unc = 0.0077, p-FDR = 0.0387) (<xref rid="fig1" ref-type="fig">Figure 1D</xref>). Baseline functional connectivity within the bilateral orbitofrontal nodes of the limbic network was positively associated with subjective drinking reduction after 30 days of intervention (F[1,33] = 6.53, p-unc = 0.0154, p-FDR = 0.0462) (<xref rid="fig1" ref-type="fig">Figure 1B</xref>).</p>
      </sec>
      <sec id="sec25">
        <title>Functional connectivity at the post-CM period: effect of drinking reduction</title>
        <p>Neither within- nor between-networks functional connectivity at the 30-day follow-up was associated with drinking reduction as determined by percent reduction of TAC-AUC. Within-network DMN functional connectivity at the 30-day follow-up was significantly negatively associated with self-reported drinking reduction on the TLFB (F[2,32] = 7.68, p-unc = 0.0019, p-FDR = 0.0113) (<xref rid="fig1" ref-type="fig">Figure 1C</xref>).</p>
      </sec>
      <sec id="sec26">
        <title>Post-CM change in functional connectivity</title>
        <p>After 30-days of attempted abstinence from heavy drinking, between-networks functional connectivity significantly increased as a function of objective reduction in alcohol use as determined by TAC-AUC. Specifically, a connectivity increase was observed between the limbic and frontoparietal control network (t[30] = 2.54, <italic>p</italic> = 0.008) driven by the cingulate region of the fronto-parietal control network and the orbitofrontal cortex of the limbic network (F[2,25] = 8.27, p-unc = 0.0017, p-FDR = 0.0315) (<xref rid="fig1" ref-type="fig">Figure 1E</xref>). There were no within-network associations observed between functional connectivity change and objective drinking reduction via TAC-AUC. Similarly, no within- or between-network changes in functional connectivity were observed as a function of self-reported drinking reduction on the TLFB.</p>
      </sec>
      <sec id="sec27">
        <title>HIV associations with rsfMRI connectivity</title>
        <p>As seen in the lower half of <xref rid="tab1" ref-type="table">Table 1</xref>, PLWH demonstrated a statistically lower percent reduction in self-reported drinking compared to people without HIV (t[33] = −2.12, <italic>p</italic> = 0.047), thus necessitating a comparison of these groups when examining the effect of intervention on resting-state connectivity. Results revealed a significant main effect of HIV diagnosis and DAN connectivity at baseline for self-reported percent alcohol reduction (t[34] = 20.5; <italic>p</italic> &lt; 0.001) as well as a significant interactive effect of HIV status and baseline DAN connectivity (t[34] = 2.11; <italic>p</italic> = 0.043). There was also a significant main effect of HIV status and DAN connectivity at baseline for objective percent drinking reduction on SCRAM (t[31] = 20.0; <italic>p</italic> &lt; 0.001) as well as a significant interactive effect of HIV status and baseline DAN connectivity (t[31] = 2.63; <italic>p</italic> = 0.014) (<xref rid="fig2" ref-type="fig">Figure 2</xref>). There were no main effects of HIV status on objective or self-reported percent drinking reduction for any of the five networks at the 30-day follow-up. Similarly, there were no main effects of HIV status on objective or self-reported percent drinking reduction for change in connectivity within the five networks examined.</p>
        <fig position="float" id="fig2">
          <label>Figure 2</label>
          <caption>
            <p>Interactive effect of baseline Dorsal Attention Network connectivity predicting percent reduction in objective drinking (SCRAM) and subjective drinking (TLFB) as a function of HIV status.</p>
          </caption>
          <graphic xlink:href="fpsyt-14-1102368-g002" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussions" id="sec28">
      <title>Discussion</title>
      <p>Although recent advances in neuroimaging techniques have provided insights into functional changes associated with heavy drinking, longitudinal studies assessing functional mechanisms of drinking reduction are rare, especially in PLWH. Following short-term abstinence from alcohol, the current literature indicates that individuals experience greater activity in limbic-striatal regions and lower activity in the medial frontal and cingulated regions, suggestive of difficulties with emotional regulation, self-control, and executive functioning (<xref rid="ref28" ref-type="bibr">28</xref>, <xref rid="ref35" ref-type="bibr">35</xref>). As such, the purpose of the present study was to determine the ability of baseline resting-state functional MRI (rsfMRI) connectivity to predict later reduction in heavy alcohol use as well as how rsfMRI connectivity is altered after 30 days of attempted abstinence from heavy alcohol use. The present study adds to the neuroimaging literature on AUD by identifying changes in resting state functional connectivity associated with drinking reduction, rather than total abstinence, following a contingency management intervention. Furthermore, given that no study to date has examined the association of wearable biosensor detected alcohol use and brain biomarkers, we compared measures of objective (biosensor-based) and subjective (self-report) drinking reduction to neurobiological changes in individuals living with and without HIV.</p>
      <p>Results of the present analysis indicated increased between-networks connectivity between the limbic and fronto-parietal control networks in those who demonstrated higher objective abstinence from alcohol. Given the unique nature of the present study, extant literature is limited when investigating between-networks change in rsfMRI connectivity after alcohol reduction. However, this finding suggests a potential improvement in functional network coherence given that previous rsfMRI studies in clinical populations have demonstrated widespread decreases in intranetwork and internetwork correlations, such as in normal aging (<xref rid="ref80" ref-type="bibr">80</xref>) as well as with increasing severity of Alzheimer’s Disease (<xref rid="ref77" ref-type="bibr">77</xref>, <xref rid="ref78" ref-type="bibr">78</xref>). Alternatively, it is possible that increased between-networks connectivity may indicate a “bleeding together” of the typically disparate co-activation patterns due to disruption of physiological and/or neurological homeostasis associated with prolonged alcohol use. However, to confirm that this increase in between-networks connectivity was not the result of decreased network segregation, we additionally completed a segregation analysis following previously described methods (<xref rid="ref81" ref-type="bibr">81</xref>, <xref rid="ref82" ref-type="bibr">82</xref>). These post-hoc findings suggested an overall net increase in between-networks connectivity, indicating increased between-networks segregation from pre-to-post-intervention. These results suggest that these networks maintained unique network connectivity patterns following alcohol reduction in our sample, providing further confidence that the changes in resting-state synchronicity following alcohol reduction indicates improved functional connectivity.</p>
      <p>The second major finding of our analysis was lower resting-state functional connectivity of the salience network at baseline was associated with greater post-intervention drinking reduction in individuals who exhibit heavy alcohol consumption. The salience network refers to the co-activation of brain regions, such as the anterior cingulate and ventral anterior insular cortices, as well as the amygdala, hypothalamus, ventral striatum, thalamus, and specific brainstem nuclei with domain-specific functions separating the most relevant internal and extra-personal stimuli to guide goal-directed behavior (<xref rid="ref17" ref-type="bibr">17</xref>). According to the neuro-circuitry model of addiction, these two brain regions appear to influence the dynamics between large-scale brain networks enhancing salience for alcohol-related cues while inhibiting the response to other stimuli (<xref rid="ref83" ref-type="bibr">83</xref>, <xref rid="ref84" ref-type="bibr">84</xref>). Therefore, our results suggest that individuals who engage in heavy alcohol use and have lower Salience network resting state functional connectivity at baseline may be less susceptible to the environmental (e.g., alcohol advertisements, billboards, etc.) and social cues (e.g., social gatherings, peer pressure, etc.) that tend to make attempts at alcohol abstinence unsuccessful. In other words, the appetitive synchrony in the salience network associated with long-term alcohol use may render individuals with AUD more vulnerable to alcohol craving and repeated consumption, but individuals with lower resting state functional connectivity in these areas at rest may be better able to engage in drinking reduction approaches.</p>
      <p>This study also revealed some important findings in regard to differences between self-reported alcohol use and objective alcohol use in how they relate to baseline rsfMRI connectivity as well as change in connectivity after alcohol reduction. Self-reported alcohol use but not objective alcohol use metrics in the pre-CM period was related to baseline DAN connectivity. As such, it is possible that increased baseline engagement of this network may be related to the cognitive ability for self-apprasial and self-reporting alcohol use, but not for actual alcohol consumption itself. Such an interpretation would reveal why objective alcohol use is not related to baseline DAN connectivity and why DAN connectivity at baseline predicts alcohol reduction after intervention without a post-CM change in DAN functional connectivity. We also found a positive association between limbic connectivity and subjective report of alcohol use reduction after CM (<xref rid="ref85" ref-type="bibr">85</xref>). Previous studies in other clinical populations, such as those suffering from major depressive disorder (MDD) have found depression symptoms to be related to limbic network connectivity and that increased connectivity in this network is observed after antidepressant treatment. As such, it is possible that mood alterations resulting from decreased alcohol use are driving associations of self-reported drinking reduction and limibic connectivity (<xref rid="ref86" ref-type="bibr">86</xref>). Further, one question this investigation elicits is in regard to the lack of rsfMRI connectivity associations with drinking reduction at the follow-up period despite associations with <italic>change</italic> in rsfMRI connectivity. It is possible that change in drinking, as a metric, is more readily associated with change in rsfMRI connectivity, but that other health or mood factors at follow-up, such as improved ART medication adherence or depressive symptom reporting, are more strongly linked to an individual’s present rsfMRI connectivity patterns after drinking reduction. Such a study would provide increased clinical utility of rsfMRI connectivity in relation to drinking reduction and its effect on clinically-applicable and measurable changes after intervention. As such, future investigations should examine medication adherence, depression symptom reporting, and other health-related factors in relation to enduring rsfMRI connectivity patterns after a short period of drinking reduction.</p>
      <p>Finally, results revealed a significant main effect of HIV diagnosis and DAN connectivity at baseline for self-reported percent alcohol reduction. Additionally, there was a significant interactive effect of HIV status and baseline DAN connectivity such that higher DAN connectivity at baseline was predictive of greater drinking reduction in PLWH. The DAN is thought to underlie selective visual attention (<xref rid="ref87" ref-type="bibr">87</xref>, <xref rid="ref88" ref-type="bibr">88</xref>), which is particularly important for goal-directed behavior. Previous rsfMRI research has demonstrated abnormal functional connectivity in the DAN in patients with alcohol-use disorder (<xref rid="ref89" ref-type="bibr">89</xref>). Therefore, our findings may suggest a disruption of DAN connectivity in PLWH who use alcohol, making it more difficult for individuals living with HIV to maintain abstinence. This finding also ties into the previously described finding of decreased salience network connectivity predicting greater post-intervention alcohol reduction. As the DAN is engaged during externally directed attention, salient environmental cues may be particularly important for reinforcing alcohol consumption in PLWH with heavy alcohol use histories. Important for the present study, our data suggest that PLWH with disrupted DAN connectivity may not benefit as greatly from CM for alcohol reduction as those with higher levels of within-network DAN connectivity at baseline.</p>
      <p>We acknowledge some limitations in the current study. First, while this study included a longitudinal design with two data points per participant, the sample size was relatively small and thus limiting power and generalizability. Further, participants in the present study were moderate-to-heavy drinkers but were not dependent on alcohol. Therefore, resting state synchrony should be examined in a larger sample comprising adults with greater severity of alcohol dependence. Additionally, this study examined a set of statistical inferences simultaneously, lending to an issue of multiple comparisons. However, when all networks were evaluated in a single model liberally correcting for multiplicity, increased between-networks connectivity in those with higher abstinence remained significant, suggesting that this is a robust finding despite a small sample size. Relatedly, some HIV-related factors that may have influenced the findings were not considered due to the limited sample size, and future analyses should examine the impact of HIV duration, viral load, AIDS, antiretroviral therapy (ART), duration on ART, CD4 nadir, and CD4 t-cell count. Third, this study was not a randomized clinical trial, meaning participants were not randomized to intervention or control groups. Therefore, conclusions cannot be drawn regarding the efficacy of the contingency management intervention as all participants had the opportunity to receive financial incentives to reduce drinking. Future research should examine the use of non-monetary incentives for drinking reduction (e.g., vouchers, prizes, etc.). Similarly, the alcohol reduction and CM effects on rs-fMRI networks cannot be differentiated in this study. Despite these weaknesses, this is the first study to our knowledge that examined resting state synchrony pre- and post-drinking reduction in a sample of individuals with and without HIV.</p>
    </sec>
    <sec sec-type="conclusions" id="sec29">
      <title>Conclusion</title>
      <p>Overall, the present study sought to determine the effects of 30-days drinking cessation/reduction on resting state functional connectivity in people with and without HIV. We found that lower resting-state functional connectivity of the Salience network significantly predicted stronger drinking reduction, and greater drinking reduction following CM was associated with increased between-networks connectivity. Consistent with previous research, our findings also demonstrated a disruption of DAN connectivity in PLWH who use alcohol, making it more difficult for individuals living with HIV and who had lower DAN connectivity to maintain abstinence with CM; this finding was corroborated by results indicating that PLWH with lower DAN connectivity were less successful at drinking reduction following CM compared to those without HIV. These findings not only suggest a potential biomarker for reduced susceptibility to the environmental and social cues that often make alcohol use reduction attempts unsuccessful, but also indicate that individuals experience benefits in brain connectivity associated with reduced drinking. Therefore, FC alterations associated with chronic alcohol use may be reversible, and may serve as clinical biomarkers of change in drinking behaviors for future studies which do not employ wearable biosensor monitoring devices.</p>
    </sec>
    <sec sec-type="data-availability" id="sec30">
      <title>Data availability statement</title>
      <p>The raw data supporting the conclusions of this article will be made available by the authors by request, without undue reservation.</p>
    </sec>
    <sec id="sec31">
      <title>Ethics statement</title>
      <p>The studies involving human participants were reviewed and approved by the University of Florida Institutional Review Board and University of Miami Institutional Review Board. The patients/participants provided their written informed consent to participate in this study.</p>
    </sec>
    <sec id="sec32">
      <title>Author contributions</title>
      <p>JG contributed to conception and design of the study and performed the statistical analysis. JG and JD wrote the manuscript. ZZ organized the database. RAC and RLC acquired funding for the study. VG and TS supervised the data collection. All authors contributed to the manuscript revision, read, and approved the submitted version.</p>
    </sec>
    <sec sec-type="funding-information" id="sec33">
      <title>Funding</title>
      <p>This project was supported by NIH grants T32-DA017629 and U01-AA020797-10.</p>
    </sec>
    <sec sec-type="COI-statement" id="conf1">
      <title>Conflict of interest</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
    <sec sec-type="disclaimer" id="sec100">
      <title>Publisher’s note</title>
      <p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duko</surname><given-names>B</given-names></name><name><surname>Ayalew</surname><given-names>M</given-names></name><name><surname>Ayano</surname><given-names>G</given-names></name></person-group>. <article-title>The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis</article-title>. <source>Subst Abuse Treat Prev Policy</source>. (<year>2019</year>) <volume>14</volume>:<fpage>52</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13011-019-0240-3</pub-id>, PMID: <pub-id pub-id-type="pmid">31727086</pub-id></mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orwat</surname><given-names>J</given-names></name><name><surname>Saitz</surname><given-names>R</given-names></name><name><surname>Tompkins</surname><given-names>CP</given-names></name><name><surname>Cheng</surname><given-names>DM</given-names></name><name><surname>Dentato</surname><given-names>MP</given-names></name><name><surname>Samet</surname><given-names>JH</given-names></name></person-group>. <article-title>Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems</article-title>. <source>J Subst Abus Treat</source>. (<year>2011</year>) <volume>41</volume>:<fpage>233</fpage>–<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jsat.2011.04.002</pub-id>, PMID: <pub-id pub-id-type="pmid">21700412</pub-id></mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonacini</surname><given-names>M</given-names></name></person-group>. <article-title>Alcohol use among patients with HIV infection</article-title>. <source>Ann Hepatol</source>. (<year>2011</year>) <volume>10</volume>:<fpage>502</fpage>–<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1665-2681(19)31519-4</pub-id><pub-id pub-id-type="pmid">21911892</pub-id></mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahler</surname><given-names>CW</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Cioe</surname><given-names>PA</given-names></name><name><surname>Bryant</surname><given-names>V</given-names></name><name><surname>Pinkston</surname><given-names>MM</given-names></name><name><surname>Kojic</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>Direct and indirect effects of heavy alcohol use on clinical outcomes in a longitudinal study of HIV patients on ART</article-title>. <source>AIDS Behav</source>. (<year>2017</year>) <volume>21</volume>:<fpage>1825</fpage>–<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10461-016-1474-y</pub-id>, PMID: <pub-id pub-id-type="pmid">27392417</pub-id></mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conigliaro</surname><given-names>J</given-names></name><name><surname>Madenwald</surname><given-names>T</given-names></name><name><surname>Bryant</surname><given-names>K</given-names></name><name><surname>Braithwaite</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>A</given-names></name><name><surname>Fultz</surname><given-names>SL</given-names></name><etal/></person-group>. <article-title>The veterans aging cohort study: observational studies of alcohol use, abuse, and outcomes among human immunodeficiency virus-infected veterans</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2004</year>) <volume>28</volume>:<fpage>313</fpage>–<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.ALC.0000113414.73220.21</pub-id>, PMID: <pub-id pub-id-type="pmid">15112939</pub-id></mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>DB</given-names></name><name><surname>Buchacz</surname><given-names>K</given-names></name><name><surname>Gebo</surname><given-names>KA</given-names></name><name><surname>Hessol</surname><given-names>NA</given-names></name><name><surname>Horberg</surname><given-names>MA</given-names></name><name><surname>Jacobson</surname><given-names>LP</given-names></name><etal/></person-group>. <article-title>Trends and disparities in antiretroviral therapy initiation and Virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009</article-title>. <source>Clin Infect Dis</source>. (<year>2013</year>) <volume>56</volume>:<fpage>1174</fpage>–<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cid/cit003</pub-id>, PMID: <pub-id pub-id-type="pmid">23315317</pub-id></mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>T</given-names></name><name><surname>Blonigen</surname><given-names>DM</given-names></name><name><surname>Upah</surname><given-names>R</given-names></name><name><surname>Justice</surname><given-names>A</given-names></name></person-group>. <article-title>Lifetime drinking trajectories among veterans in treatment for HIV</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2013</year>) <volume>37</volume>:<fpage>1179</fpage>–<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acer.12071</pub-id>, PMID: <pub-id pub-id-type="pmid">23448171</pub-id></mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justice</surname><given-names>AC</given-names></name><name><surname>McGinnis</surname><given-names>KA</given-names></name><name><surname>Skanderson</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Gibert</surname><given-names>CL</given-names></name><name><surname>Goetz</surname><given-names>MB</given-names></name><etal/></person-group>. <article-title>Towards a combined prognostic index for survival in HIV infection: the role of ‘non-HIV’ biomarkers</article-title>. <source>HIV Med</source>. (<year>2010</year>) <volume>11</volume>:<fpage>143</fpage>–<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1468-1293.2009.00757.x</pub-id>, PMID: <pub-id pub-id-type="pmid">19751364</pub-id></mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korthuis</surname><given-names>PT</given-names></name><name><surname>Fiellin</surname><given-names>DA</given-names></name><name><surname>McGinnis</surname><given-names>KA</given-names></name><name><surname>Skanderson</surname><given-names>M</given-names></name><name><surname>Justice</surname><given-names>AC</given-names></name><name><surname>Gordon</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care</article-title>. <source>J Acquir Immune Defic Syndr</source>. (<year>2012</year>) <volume>61</volume>:<fpage>171</fpage>–<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAI.0b013e31826741aa</pub-id>, PMID: <pub-id pub-id-type="pmid">22820808</pub-id></mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monnig</surname><given-names>MA</given-names></name><name><surname>Kahler</surname><given-names>CW</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Pantalone</surname><given-names>DW</given-names></name><name><surname>Mayer</surname><given-names>KH</given-names></name><name><surname>Cohen</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Effects of smoking and alcohol use on neurocognitive functioning in heavy drinking, HIV-positive men who have sex with men</article-title>. <source>AIDS Care</source>. (<year>2016</year>) <volume>28</volume>:<fpage>300</fpage>–<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09540121.2015.1093595</pub-id>, PMID: <pub-id pub-id-type="pmid">26444260</pub-id></mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothlind</surname><given-names>JC</given-names></name><name><surname>Greenfield</surname><given-names>TM</given-names></name><name><surname>Bruce</surname><given-names>AV</given-names></name><name><surname>Meyerhoff</surname><given-names>DJ</given-names></name><name><surname>Flenniken</surname><given-names>DL</given-names></name><name><surname>Lindgren</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance</article-title>. <source>J Int Neuropsychol Soc</source>. (<year>2005</year>) <volume>11</volume>:<fpage>70</fpage>–<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S1355617705050095</pub-id>, PMID: <pub-id pub-id-type="pmid">15686610</pub-id></mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbloom</surname><given-names>MJ</given-names></name><name><surname>Sullivan</surname><given-names>EV</given-names></name></person-group>. <article-title>Focus on the brain: HIV infection</article-title>. <source>Alcohol Res Health</source>. (<year>2010</year>) <volume>33</volume>:<fpage>247</fpage>–<lpage>57</lpage>. PMID: <pub-id pub-id-type="pmid">23584066</pub-id></mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gullett</surname><given-names>JM</given-names></name><name><surname>Lamb</surname><given-names>DG</given-names></name><name><surname>Porges</surname><given-names>E</given-names></name><name><surname>Woods</surname><given-names>AJ</given-names></name><name><surname>Rieke</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>The impact of alcohol use on frontal white matter in HIV</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2018</year>) <volume>42</volume>:<fpage>1640</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acer.13823</pub-id>, PMID: <pub-id pub-id-type="pmid">29957870</pub-id></mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname><given-names>VE</given-names></name><name><surname>Gullett</surname><given-names>JM</given-names></name><name><surname>Porges</surname><given-names>EC</given-names></name><name><surname>Cook</surname><given-names>RL</given-names></name><name><surname>Bryant</surname><given-names>KJ</given-names></name><name><surname>Woods</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>History of alcohol consumption and HIV status related to functional connectivity differences in the brain during working memory performance</article-title>. <source>Curr HIV Res</source>. (<year>2020</year>) <volume>18</volume>:<fpage>181</fpage>–<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1570162x18666200217100123</pub-id>, PMID: <pub-id pub-id-type="pmid">32065091</pub-id></mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raichle</surname><given-names>ME</given-names></name></person-group>. <article-title>The Brain’s default mode network</article-title>. <source>Annu Rev Neurosci</source>. (<year>2015</year>) <volume>38</volume>:<fpage>433</fpage>–<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-neuro-071013-014030</pub-id><pub-id pub-id-type="pmid">25938726</pub-id></mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osher</surname><given-names>D</given-names></name><name><surname>Tobyne</surname><given-names>S</given-names></name><name><surname>Brissenden</surname><given-names>J</given-names></name><name><surname>Noyce</surname><given-names>A</given-names></name><name><surname>Michalka</surname><given-names>S</given-names></name><name><surname>Levin</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Predicting an Individual’s own dorsal attention network from their functional connectivity fingerprint</article-title>. <source>J Vis</source>. (<year>2017</year>) <volume>17</volume>:<fpage>525</fpage>. doi: <pub-id pub-id-type="doi">10.1167/17.10.525</pub-id></mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeley</surname><given-names>WW</given-names></name></person-group>. <article-title>The salience network: a neural system for perceiving and responding to homeostatic demands</article-title>. <source>J Neurosci</source>. (<year>2019</year>) <volume>39</volume>:<fpage>9878</fpage>–<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1138-17.2019</pub-id>, PMID: <pub-id pub-id-type="pmid">31676604</pub-id></mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Torrico</surname><given-names>TJ</given-names></name><name><surname>Abdijadid</surname><given-names>S</given-names></name></person-group>. <source>Neuroanatomy, limbic system</source>. <publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>StatsPearls</publisher-name> (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marek</surname><given-names>S</given-names></name><name><surname>Dosenbach</surname><given-names>NUF</given-names></name></person-group>. <article-title>The Frontoparietal network: function, electrophysiology, and importance of individual precision mapping</article-title>. <source>Dialogues Clin Neurosci</source>. (<year>2018</year>) <volume>20</volume>:<fpage>133</fpage>–<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.31887/dcns.2018.20.2/smarek</pub-id>, PMID: <pub-id pub-id-type="pmid">30250390</pub-id></mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamarajan</surname><given-names>C</given-names></name><name><surname>Bernice</surname><given-names>P</given-names></name><name><surname>Kevin</surname><given-names>AJ</given-names></name><name><surname>Keewhan</surname><given-names>C</given-names></name><name><surname>David</surname><given-names>B. C</given-names></name><name><surname>Ajayan</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Alcoholism Is a Disinhibitory Disorder: Neurophysiological Evidence from a Go/No-Go Task</article-title>. <source>Biol Psychol</source>. (<year>2005</year>) <volume>69</volume>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsycho.2004.08.004</pub-id></mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akine</surname><given-names>Y</given-names></name><name><surname>Motoichiro</surname><given-names>K</given-names></name><name><surname>Taro</surname><given-names>M</given-names></name><name><surname>Satoshi</surname><given-names>U</given-names></name><name><surname>Masaru</surname><given-names>M</given-names></name><name><surname>Yoshiyuki</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Altered Brain Activation by a False Recognition Task in Young Abstinent Patients with Alcohol Dependence</article-title>. <source>Alcoholism: Clinical and Experimental Research</source>. (<year>2007</year>) <volume>31</volume>. doi: <pub-id pub-id-type="doi">10.1111/j.1530-0277.2007.00453.x</pub-id></mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Shan</surname><given-names>R</given-names></name><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Peisi</surname><given-names>Y</given-names></name><name><surname>Keri</surname><given-names>B</given-names></name><name><surname>Rajita</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Altered Impulse Control in Alcohol Dependence: Neural Measures of Stop Signal Performance</article-title>. <source>Alcoholism Clin Exp Res</source>. (<year>2009</year>) <volume>33</volume>. doi: <pub-id pub-id-type="doi">10.1111/j.1530-0277.2008.00891.x</pub-id></mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M-S</given-names></name><name><surname>Sunju</surname><given-names>S</given-names></name><name><surname>Ji-Eun</surname><given-names>P</given-names></name><name><surname>Sook-Hee</surname><given-names>K</given-names></name><name><surname>Kyu</surname><given-names>Y</given-names></name><name><surname>Jin-Hun</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Brain Functions Associated with Verbal Working Memory Tasks among Young Males with Alcohol Use Disorders</article-title>. <source>Scand J Psychol</source>. (<year>2011</year>) <volume>52</volume>:<fpage>1</fpage>–<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-9450.2010.00848.x</pub-id><pub-id pub-id-type="pmid">21054421</pub-id></mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pariyadath</surname><given-names>V</given-names></name><name><surname>Gowin</surname><given-names>JL</given-names></name><name><surname>Stein</surname><given-names>EA</given-names></name></person-group>. <article-title>Resting state functional connectivity analysis for addiction medicine: from individual loci to complex networks</article-title>. <source>Prog Brain Res</source>. (<year>2016</year>) <volume>224</volume>:<fpage>155</fpage>–<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.pbr.2015.07.015</pub-id><pub-id pub-id-type="pmid">26822358</pub-id></mixed-citation>
      </ref>
      <ref id="ref25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamarajan</surname><given-names>C</given-names></name><name><surname>Ardekani</surname><given-names>BA</given-names></name><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Kinreich</surname><given-names>S</given-names></name><name><surname>Pandey</surname><given-names>G</given-names></name><name><surname>Chorlian</surname><given-names>DB</given-names></name><etal/></person-group>. <article-title>Differentiating Individuals with and without Alcohol Use Disorder Using Resting-State fMRI Functional Connectivity of Reward Network, Neuropsychological Performance, and Impulsivity Measures</article-title>. <source>Behavioral sciences (Basel, Switzerland)</source>. (<year>2022</year>) <volume>12</volume>:<fpage>128</fpage>. doi: <pub-id pub-id-type="doi">10.3390/bs12050128</pub-id><pub-id pub-id-type="pmid">35621425</pub-id></mixed-citation>
      </ref>
      <ref id="ref26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camchong</surname><given-names>J</given-names></name><name><surname>Stenger</surname><given-names>VA</given-names></name><name><surname>Fein</surname><given-names>G</given-names></name></person-group>. <article-title>Resting-state synchrony in short-term versus Long-term abstinent alcoholics</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2013</year>) <volume>37</volume>:<fpage>794</fpage>–<lpage>803</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acer.12037</pub-id>, PMID: <pub-id pub-id-type="pmid">23421812</pub-id></mixed-citation>
      </ref>
      <ref id="ref27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Cortes</surname><given-names>CR</given-names></name><name><surname>Mathur</surname><given-names>K</given-names></name><name><surname>Tomasi</surname><given-names>D</given-names></name><name><surname>Momenan</surname><given-names>R</given-names></name></person-group>. <article-title>Model-free functional connectivity and impulsivity correlates of alcohol dependence: a resting-state study</article-title>. <source>Addiction biology</source>. (<year>2017</year>) <volume>22</volume>:<fpage>206</fpage>–<lpage>217</lpage>. doi: <pub-id pub-id-type="doi">10.1111/adb.12272</pub-id><pub-id pub-id-type="pmid">26040546</pub-id></mixed-citation>
      </ref>
      <ref id="ref28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanraud</surname><given-names>S</given-names></name><name><surname>Pitel</surname><given-names>AL</given-names></name><name><surname>Pfefferbaum</surname><given-names>A</given-names></name><name><surname>Edith</surname><given-names>VS</given-names></name></person-group>. <article-title>Disruption of functional connectivity of the default-mode network in alcoholism</article-title>. <source>Cereb Cortex</source>. (<year>2011</year>) <volume>21</volume>:<fpage>2272</fpage>–<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cercor/bhq297</pub-id>, PMID: <pub-id pub-id-type="pmid">21368086</pub-id></mixed-citation>
      </ref>
      <ref id="ref29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breese</surname><given-names>GR</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Heilig</surname><given-names>M</given-names></name></person-group>. <article-title>Chronic alcohol Neuroadaptation and stress contribute to susceptibility for alcohol craving and Relapse</article-title>. <source>Pharmacol Ther</source>. (<year>2011</year>) <volume>129</volume>:<fpage>149</fpage>–<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pharmthera.2010.09.007</pub-id>, PMID: <pub-id pub-id-type="pmid">20951730</pub-id></mixed-citation>
      </ref>
      <ref id="ref30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>D</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name></person-group>. <article-title>Prefrontal limbic-striatal circuits and alcohol addiction in humans</article-title>. <source>Neurobiol Alcohol Depend</source>. (<year>2014</year>):<fpage>49</fpage>–<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-12-405941-2.00003-1</pub-id></mixed-citation>
      </ref>
      <ref id="ref31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>D</given-names></name><name><surname>Lacadie</surname><given-names>C</given-names></name><name><surname>Bergquist</surname><given-names>K</given-names></name><name><surname>Constable</surname><given-names>TR</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name></person-group>. <article-title>Disrupted ventromedial prefrontal cortex function during stress and neutral-relaxed states is predictive of alcohol relapse outcomes</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2010</year>) <volume>34</volume>:<fpage>161A</fpage>–<lpage>161A</lpage>.</mixed-citation>
      </ref>
      <ref id="ref32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>R</given-names></name></person-group>. <article-title>The role of stress in addiction Relapse</article-title>. <source>Curr Psychiatry Rep</source>. (<year>2007</year>) <volume>9</volume>:<fpage>388</fpage>–<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11920-007-0050-6</pub-id><pub-id pub-id-type="pmid">17915078</pub-id></mixed-citation>
      </ref>
      <ref id="ref33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>CSR</given-names></name></person-group>. <article-title>Imaging stress- and Cue-induced drug and alcohol craving: association with Relapse and clinical implications</article-title>. <source>Drug Alcohol Rev</source>. (<year>2007</year>) <volume>26</volume>:<fpage>25</fpage>–<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09595230601036960</pub-id>, PMID: <pub-id pub-id-type="pmid">17364833</pub-id></mixed-citation>
      </ref>
      <ref id="ref34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohno</surname><given-names>M</given-names></name><name><surname>Dennis</surname><given-names>LE</given-names></name><name><surname>McCready</surname><given-names>H</given-names></name><name><surname>Hoffman</surname><given-names>WF</given-names></name></person-group>. <article-title>Executive control and striatal resting-state network interact with risk factors to influence treatment outcomes in alcohol-use disorder</article-title>. <source>Front Psychiat</source>. (<year>2017</year>) <volume>8</volume>:<fpage>182</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2017.00182</pub-id></mixed-citation>
      </ref>
      <ref id="ref35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camchong</surname><given-names>J</given-names></name><name><surname>Stenger</surname><given-names>A</given-names></name><name><surname>Fein</surname><given-names>G</given-names></name></person-group>. <article-title>Resting-state synchrony during early alcohol abstinence can predict subsequent Relapse</article-title>. <source>Cereb Cortex</source>. (<year>2013</year>) <volume>23</volume>:<fpage>2086</fpage>–<lpage>99</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cercor/bhs190</pub-id>, PMID: <pub-id pub-id-type="pmid">22819968</pub-id></mixed-citation>
      </ref>
      <ref id="ref36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>du Plessis</surname><given-names>S</given-names></name><name><surname>Vink</surname><given-names>M</given-names></name><name><surname>Joska</surname><given-names>JA</given-names></name><name><surname>Koutsilieri</surname><given-names>E</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Emsley</surname><given-names>R</given-names></name></person-group>. <article-title>HIV infection and the Fronto-striatal system: a systematic review and meta-analysis of FMRI studies</article-title>. <source>AIDS</source>. (<year>2014</year>) <volume>28</volume>:<fpage>803</fpage>–<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000000151</pub-id>, PMID: <pub-id pub-id-type="pmid">24300546</pub-id></mixed-citation>
      </ref>
      <ref id="ref37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>JB</given-names></name><name><surname>Brier</surname><given-names>MR</given-names></name><name><surname>Snyder</surname><given-names>AZ</given-names></name><name><surname>Vaida</surname><given-names>FF</given-names></name><name><surname>Ances</surname><given-names>BM</given-names></name></person-group>. <article-title>Pathways to Neurodegeneration: effects of HIV and aging on resting-state functional connectivity</article-title>. <source>Neurology</source>. (<year>2013</year>) <volume>80</volume>:<fpage>1186</fpage>–<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0b013e318288792b</pub-id>, PMID: <pub-id pub-id-type="pmid">23446675</pub-id></mixed-citation>
      </ref>
      <ref id="ref38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Rui</surname><given-names>H</given-names></name><name><surname>Tivarus</surname><given-names>M</given-names></name><name><surname>Ekholm</surname><given-names>S</given-names></name><name><surname>Harezlak</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study</article-title>. <source>J Neurovirol</source>. (<year>2013</year>) <volume>19</volume>:<fpage>10</fpage>–<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13365-012-0135-9</pub-id>, PMID: <pub-id pub-id-type="pmid">23179680</pub-id></mixed-citation>
      </ref>
      <ref id="ref39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>JL</given-names></name></person-group>. <article-title>Anatomic and behavioral aspects of frontal-subcortical circuits</article-title>. <source>Ann N Y Acad Sci</source>. (<year>1995</year>) <volume>769</volume>:<fpage>1</fpage>–<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1749-6632.1995.tb38127.x</pub-id>, PMID: <pub-id pub-id-type="pmid">8595019</pub-id></mixed-citation>
      </ref>
      <ref id="ref40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>JP</given-names></name><name><surname>Heil</surname><given-names>SH</given-names></name><name><surname>Mongeon</surname><given-names>JA</given-names></name><name><surname>Badger</surname><given-names>GJ</given-names></name><name><surname>Higgins</surname><given-names>ST</given-names></name></person-group>. <article-title>A meta-analysis of voucher-based reinforcement therapy for substance use disorders</article-title>. <source>Addiction</source>. (<year>2006</year>) <volume>101</volume>:<fpage>192</fpage>–<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1360-0443.2006.01311.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16445548</pub-id></mixed-citation>
      </ref>
      <ref id="ref41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prendergast</surname><given-names>M</given-names></name><name><surname>Podus</surname><given-names>D</given-names></name><name><surname>Finney</surname><given-names>J</given-names></name><name><surname>Greenwell</surname><given-names>L</given-names></name><name><surname>Roll</surname><given-names>J</given-names></name></person-group>. <article-title>Contingency Management for Treatment of substance use disorders: a meta-analysis</article-title>. <source>Addiction</source>. (<year>2006</year>) <volume>101</volume>:<fpage>1546</fpage>–<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1360-0443.2006.01581.x</pub-id><pub-id pub-id-type="pmid">17034434</pub-id></mixed-citation>
      </ref>
      <ref id="ref42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>ST</given-names></name><name><surname>Petry</surname><given-names>NM</given-names></name></person-group>. <article-title>Contingency management: incentives for sobriety</article-title>. <source>Alcohol Res Health</source>. (<year>1999</year>) <volume>23</volume>:<fpage>122</fpage>–<lpage>7</lpage>. PMID: <pub-id pub-id-type="pmid">10890806</pub-id></mixed-citation>
      </ref>
      <ref id="ref43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamson</surname><given-names>SJ</given-names></name><name><surname>Heather</surname><given-names>N</given-names></name><name><surname>Morton</surname><given-names>V</given-names></name><name><surname>Raistrick</surname><given-names>D</given-names></name></person-group>. <article-title>Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes</article-title>. <source>Alcohol Alcohol</source>. (<year>2010</year>) <volume>45</volume>:<fpage>136</fpage>–<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1093/alcalc/agq005</pub-id>, PMID: <pub-id pub-id-type="pmid">20130150</pub-id></mixed-citation>
      </ref>
      <ref id="ref44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>AK</given-names></name></person-group>. <article-title>Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians</article-title>. <source>J Subst Abus Treat</source>. (<year>2014</year>) <volume>46</volume>:<fpage>214</fpage>–<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jsat.2013.07.005</pub-id>, PMID: <pub-id pub-id-type="pmid">23953169</pub-id></mixed-citation>
      </ref>
      <ref id="ref45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>DA</given-names></name><name><surname>Goldstein</surname><given-names>RB</given-names></name><name><surname>Grant</surname><given-names>BF</given-names></name></person-group>. <article-title>Rates and correlates of Relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2007</year>) <volume>31</volume>:<fpage>2036</fpage>–<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1530-0277.2007.00536.x</pub-id>, PMID: <pub-id pub-id-type="pmid">18034696</pub-id></mixed-citation>
      </ref>
      <ref id="ref46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kline-Simon</surname><given-names>AH</given-names></name><name><surname>Falk</surname><given-names>DE</given-names></name><name><surname>Litten</surname><given-names>RZ</given-names></name><name><surname>Mertens</surname><given-names>JR</given-names></name><name><surname>Fertig</surname><given-names>J</given-names></name><name><surname>Ryan</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Posttreatment low-risk drinking as a predictor of future drinking and problem outcomes among individuals with alcohol use disorders</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2013</year>) <volume>37</volume>:<fpage>E373</fpage>–<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1530-0277.2012.01908.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22827502</pub-id></mixed-citation>
      </ref>
      <ref id="ref47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swift</surname><given-names>R</given-names></name></person-group>. <article-title>Direct measurement of alcohol and its metabolites</article-title>. <source>Addiction</source>. (<year>2003</year>) <volume>98</volume>:<fpage>73</fpage>–<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1359-6357.2003.00605.x</pub-id><pub-id pub-id-type="pmid">14984244</pub-id></mixed-citation>
      </ref>
      <ref id="ref48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>DM</given-names></name><name><surname>Charles</surname><given-names>NE</given-names></name><name><surname>Acheson</surname><given-names>A</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Furr</surname><given-names>RM</given-names></name><name><surname>Hill-Kapturczak</surname><given-names>N</given-names></name></person-group>. <article-title>Comparing the detection of transdermal and breath alcohol concentrations during periods of alcohol consumption ranging from moderate drinking to binge drinking</article-title>. <source>Exp Clin Psychopharmacol</source>. (<year>2012</year>) <volume>20</volume>:<fpage>373</fpage>–<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1037/a0029021</pub-id>, PMID: <pub-id pub-id-type="pmid">22708608</pub-id></mixed-citation>
      </ref>
      <ref id="ref49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill-Kapturczak</surname><given-names>N</given-names></name><name><surname>Lake</surname><given-names>SL</given-names></name><name><surname>Roache</surname><given-names>JD</given-names></name><name><surname>Cates</surname><given-names>SE</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Dougherty</surname><given-names>DM</given-names></name></person-group>. <article-title>Do variable rates of alcohol drinking Alter the ability to use transdermal alcohol monitors to estimate peak breath alcohol and Total number of drinks?</article-title>
<source>Alcohol Clin Exp Res</source>. (<year>2014</year>) <volume>38</volume>:<fpage>2517</fpage>–<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acer.12528</pub-id>, PMID: <pub-id pub-id-type="pmid">25335857</pub-id></mixed-citation>
      </ref>
      <ref id="ref50">
        <label>50.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>P</given-names></name><name><surname>McKnight</surname><given-names>A</given-names></name></person-group>. <source>Evaluating transdermal alcohol measuring devices. Report No.: DOT HS 810</source>. <publisher-loc>Washington, D.C</publisher-loc>: <publisher-name>National Highway Traffic Safety Administration</publisher-name> (<year>2007</year>).</mixed-citation>
      </ref>
      <ref id="ref51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>JT</given-names></name><name><surname>Mikulich-Gilbertson</surname><given-names>SK</given-names></name><name><surname>Long</surname><given-names>RJ</given-names></name><name><surname>Crowley</surname><given-names>TJ</given-names></name></person-group>. <article-title>Validity of transdermal alcohol monitoring: fixed and self-regulated dosing</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2006</year>) <volume>30</volume>:<fpage>26</fpage>–<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1111/J.1530-0277.2006.00004.X</pub-id>, PMID: <pub-id pub-id-type="pmid">16433729</pub-id></mixed-citation>
      </ref>
      <ref id="ref52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenfield</surname><given-names>TK</given-names></name><name><surname>Bond</surname><given-names>J</given-names></name><name><surname>Kerr</surname><given-names>WC</given-names></name></person-group>. <article-title>Biomonitoring for improving alcohol consumption surveys the new gold standard?</article-title>
<source>Alcohol Res</source>. (<year>2014</year>) <volume>36</volume>:<fpage>39</fpage>–<lpage>45</lpage>. PMID: <pub-id pub-id-type="pmid">26258999</pub-id></mixed-citation>
      </ref>
      <ref id="ref53">
        <label>53.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litten</surname><given-names>RZ</given-names></name><name><surname>Bradley</surname><given-names>AM</given-names></name><name><surname>Moss</surname><given-names>HB</given-names></name></person-group>. <article-title>Alcohol biomarkers in applied settings: recent advances and future research opportunities</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2010</year>) <volume>34</volume>:<fpage>955</fpage>–<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1530-0277.2010.01170.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20374219</pub-id></mixed-citation>
      </ref>
      <ref id="ref54">
        <label>54.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fridberg</surname><given-names>DJ</given-names></name><name><surname>Leeman</surname><given-names>RF</given-names></name><name><surname>Cook</surname><given-names>RL</given-names></name><name><surname>Porges</surname><given-names>EC</given-names></name></person-group>. <article-title>Wrist-worn alcohol biosensors: strengths, limitations, and future directions</article-title>. <source>Alcohol</source>. (<year>2019</year>) <volume>81</volume>:<fpage>83</fpage>–<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.alcohol.2018.08.013</pub-id>, PMID: <pub-id pub-id-type="pmid">30179709</pub-id></mixed-citation>
      </ref>
      <ref id="ref55">
        <label>55.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis-Martin</surname><given-names>RE</given-names></name><name><surname>Alessi</surname><given-names>SM</given-names></name><name><surname>Boudreaux</surname><given-names>ED</given-names></name></person-group>. <article-title>Alcohol use disorder in the age of technology: a review of wearable biosensors in alcohol use disorder treatment</article-title>. <source>Front Psych</source>. (<year>2021</year>) <volume>12</volume>:<fpage>642813</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2021.642813</pub-id>, PMID: <pub-id pub-id-type="pmid">33828497</pub-id></mixed-citation>
      </ref>
      <ref id="ref56">
        <label>56.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leffingwell</surname><given-names>TR</given-names></name><name><surname>Cooney</surname><given-names>NJ</given-names></name><name><surname>Murphy</surname><given-names>JG</given-names></name><name><surname>Luczak</surname><given-names>S</given-names></name><name><surname>Rosen</surname><given-names>G</given-names></name><name><surname>Dougherty</surname><given-names>DM</given-names></name><etal/></person-group>. <article-title>Continuous objective monitoring of alcohol use: twenty-first century measurement using transdermal sensors</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2013</year>) <volume>37</volume>:<fpage>16</fpage>–<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1530-0277.2012.01869.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22823467</pub-id></mixed-citation>
      </ref>
      <ref id="ref57">
        <label>57.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>DM</given-names></name><name><surname>Hill-Kapturczak</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Karns</surname><given-names>TE</given-names></name><name><surname>Lake</surname><given-names>SL</given-names></name><name><surname>Cates</surname><given-names>SE</given-names></name><etal/></person-group>. <article-title>The potential clinical utility of transdermal alcohol monitoring data to estimate the number of alcoholic drinks consumed</article-title>. <source>Addict Disord Treat</source>. (<year>2015</year>) <volume>14</volume>:<fpage>124</fpage>–<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ADT.0000000000000060</pub-id>, PMID: <pub-id pub-id-type="pmid">26500459</pub-id></mixed-citation>
      </ref>
      <ref id="ref58">
        <label>58.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnett</surname><given-names>NP</given-names></name><name><surname>Meade</surname><given-names>EB</given-names></name><name><surname>Glynn</surname><given-names>TR</given-names></name></person-group>. <article-title>Predictors of detection of alcohol use episodes using a transdermal alcohol sensor</article-title>. <source>Exp Clin Psychopharmacol</source>. (<year>2014</year>) <volume>22</volume>:<fpage>86</fpage>–<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1037/a0034821</pub-id>, PMID: <pub-id pub-id-type="pmid">24490713</pub-id></mixed-citation>
      </ref>
      <ref id="ref59">
        <label>59.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>DM</given-names></name><name><surname>Hill-Kapturczak</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Karns</surname><given-names>TE</given-names></name><name><surname>Cates</surname><given-names>SE</given-names></name><name><surname>Lake</surname><given-names>SL</given-names></name><etal/></person-group>. <article-title>Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use</article-title>. <source>Drug Alcohol Depend</source>. (<year>2014</year>) <volume>142</volume>:<fpage>301</fpage>–<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2014.06.039</pub-id>, PMID: <pub-id pub-id-type="pmid">25064019</pub-id></mixed-citation>
      </ref>
      <ref id="ref60">
        <label>60.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>VL</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Orr</surname><given-names>J</given-names></name><name><surname>Leeman</surname><given-names>RF</given-names></name><name><surname>Barnett</surname><given-names>NP</given-names></name><name><surname>Bryant</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Sociodemographic and clinical factors associated with transdermal alcohol concentration from the SCRAM biosensor among persons living with and without HIV</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2021</year>) <volume>45</volume>:<fpage>1804</fpage>–<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acer.14665</pub-id>, PMID: <pub-id pub-id-type="pmid">34342009</pub-id></mixed-citation>
      </ref>
      <ref id="ref61">
        <label>61.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>MA</given-names></name><name><surname>Turrisi</surname><given-names>RJ</given-names></name><name><surname>Smyth</surname><given-names>JM</given-names></name></person-group>. <article-title>Transdermal sensor features correlate with ecological momentary assessment drinking reports and predict alcohol-related consequences in young adults’ natural settings</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2022</year>) <volume>46</volume>:<fpage>100</fpage>–<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acer.14739</pub-id>, PMID: <pub-id pub-id-type="pmid">35066894</pub-id></mixed-citation>
      </ref>
      <ref id="ref62">
        <label>62.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>VL</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Porges</surname><given-names>EC</given-names></name><name><surname>Gullett</surname><given-names>JM</given-names></name><name><surname>Leeman</surname><given-names>RF</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Using alcohol biosensors and biomarkers to measure changes in drinking: associations between transdermal alcohol concentration, Phosphatidylethanol, and self-report in a contingency management study of persons with and without HIV</article-title>. <source>Exp Clin Psychopharmacol</source>. (<year>2023</year>). doi: <pub-id pub-id-type="doi">10.1037/pha0000637</pub-id>, PMID: <pub-id pub-id-type="pmid">36649152</pub-id></mixed-citation>
      </ref>
      <ref id="ref63">
        <label>63.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobell</surname><given-names>LC</given-names></name><name><surname>Sobell</surname><given-names>MB</given-names></name></person-group>. <article-title>Timeline follow Back. A technique for assessing self-reported alcohol consumption</article-title>. <source>Meas Alcohol Consum</source>. (<year>1992</year>).</mixed-citation>
      </ref>
      <ref id="ref64">
        <label>64.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnett</surname><given-names>NP</given-names></name><name><surname>Souza</surname><given-names>T</given-names></name><name><surname>Glynn</surname><given-names>TR</given-names></name><name><surname>Luczak</surname><given-names>SE</given-names></name><name><surname>Swift</surname><given-names>R</given-names></name></person-group>. <article-title>The transdermal alcohol sensor macro (TASMAC): a rapid data processing tool for use with the SCRAMx alcohol sensor</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2015</year>) <volume>39</volume>:<fpage>192A</fpage>.</mixed-citation>
      </ref>
      <ref id="ref65">
        <label>65.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnett</surname><given-names>NP</given-names></name><name><surname>Tidey</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>JG</given-names></name><name><surname>Swift</surname><given-names>R</given-names></name><name><surname>Colby</surname><given-names>SM</given-names></name></person-group>. <article-title>Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor</article-title>. <source>Drug Alcohol Depend</source>. (<year>2011</year>) <volume>118</volume>:<fpage>391</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2011.04.023</pub-id>, PMID: <pub-id pub-id-type="pmid">21665385</pub-id></mixed-citation>
      </ref>
      <ref id="ref66">
        <label>66.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hausman</surname><given-names>HK</given-names></name><name><surname>O’Shea</surname><given-names>A</given-names></name><name><surname>Kraft</surname><given-names>JN</given-names></name><name><surname>Boutzoukas</surname><given-names>EM</given-names></name><name><surname>Evangelista</surname><given-names>ND</given-names></name><name><surname>Van Etten</surname><given-names>EJ</given-names></name><etal/></person-group>. <article-title>The role of resting-state network functional connectivity in cognitive aging</article-title>. <source>Front Aging Neurosci</source>. (<year>2020</year>) <volume>12</volume>:<fpage>177</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2020.00177</pub-id>, PMID: <pub-id pub-id-type="pmid">32595490</pub-id></mixed-citation>
      </ref>
      <ref id="ref67">
        <label>67.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Penny</surname><given-names>W</given-names></name><name><surname>Friston</surname><given-names>K</given-names></name><name><surname>Ashburner</surname><given-names>J</given-names></name><name><surname>Kiebel</surname><given-names>S</given-names></name><name><surname>Nichols</surname><given-names>T</given-names></name></person-group>. <source>Statistical parametric mapping: the analysis of functional brain images. Statistical parametric mapping: the analysis of functional brain images</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2007</year>).</mixed-citation>
      </ref>
      <ref id="ref68">
        <label>68.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitfield-Gabrieli</surname><given-names>S</given-names></name><name><surname>Nieto-Castanon</surname><given-names>A</given-names></name></person-group>. <article-title>Conn: a functional connectivity toolbox for correlated and Anticorrelated brain networks</article-title>. <source>Brain Connect</source>. (<year>2012</year>) <volume>2</volume>:<fpage>125</fpage>–<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1089/brain.2012.0073</pub-id>, PMID: <pub-id pub-id-type="pmid">22642651</pub-id></mixed-citation>
      </ref>
      <ref id="ref69">
        <label>69.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behzadi</surname><given-names>Y</given-names></name><name><surname>Restom</surname><given-names>K</given-names></name><name><surname>Liau</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>TT</given-names></name></person-group>. <article-title>A component based noise correction method (CompCor) for BOLD and perfusion based FMRI</article-title>. <source>NeuroImage</source>. (<year>2007</year>) <volume>37</volume>:<fpage>90</fpage>–<lpage>101</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.04.042</pub-id>, PMID: <pub-id pub-id-type="pmid">17560126</pub-id></mixed-citation>
      </ref>
      <ref id="ref70">
        <label>70.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirer</surname><given-names>WR</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Price</surname><given-names>CM</given-names></name><name><surname>Ng</surname><given-names>B</given-names></name><name><surname>Greicius</surname><given-names>MD</given-names></name></person-group>. <article-title>Optimization of Rs-FMRI pre-processing for enhanced signal-noise separation, test-retest reliability, and group discrimination</article-title>. <source>NeuroImage</source>. (<year>2015</year>) <volume>117</volume>:<fpage>67</fpage>–<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.05.015</pub-id>, PMID: <pub-id pub-id-type="pmid">25987368</pub-id></mixed-citation>
      </ref>
      <ref id="ref71">
        <label>71.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas Yeo</surname><given-names>BT</given-names></name><name><surname>Krienen</surname><given-names>FM</given-names></name><name><surname>Sepulcre</surname><given-names>J</given-names></name><name><surname>Sabuncu</surname><given-names>MR</given-names></name><name><surname>Lashkari</surname><given-names>D</given-names></name><name><surname>Hollinshead</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The Organization of the Human Cerebral Cortex Estimated by intrinsic functional connectivity</article-title>. <source>J Neurophysiol</source>. (<year>2011</year>) <volume>106</volume>:<fpage>1125</fpage>–<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1152/jn.00338.2011</pub-id>, PMID: <pub-id pub-id-type="pmid">21653723</pub-id></mixed-citation>
      </ref>
      <ref id="ref72">
        <label>72.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betzel</surname><given-names>RF</given-names></name><name><surname>Byrge</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Goñi</surname><given-names>J</given-names></name><name><surname>Zuo</surname><given-names>XN</given-names></name><name><surname>Sporns</surname><given-names>O</given-names></name></person-group>. <article-title>Changes in structural and functional connectivity among resting-state networks across the human lifespan</article-title>. <source>NeuroImage</source>. (<year>2014</year>) <volume>102</volume>:<fpage>345</fpage>–<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.07.067</pub-id>, PMID: <pub-id pub-id-type="pmid">25109530</pub-id></mixed-citation>
      </ref>
      <ref id="ref73">
        <label>73.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>ML</given-names></name><name><surname>De La Vega</surname><given-names>A</given-names></name><name><surname>Mills</surname><given-names>C</given-names></name><name><surname>Jessica Andrews-Hanna</surname><given-names>R</given-names></name><name><surname>Spreng</surname><given-names>N</given-names></name><name><surname>Cole</surname><given-names>MW</given-names></name><etal/></person-group>. <article-title>Heterogeneity within the Frontoparietal control network and its relationship to the default and dorsal attention networks</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>2018</year>) <volume>115</volume>:<fpage>E1598</fpage>–<lpage>607</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1715766115</pub-id>, PMID: <pub-id pub-id-type="pmid">29382744</pub-id></mixed-citation>
      </ref>
      <ref id="ref74">
        <label>74.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname><given-names>J</given-names></name><name><surname>Galdi</surname><given-names>P</given-names></name><name><surname>Paul</surname><given-names>LK</given-names></name><name><surname>Adolphs</surname><given-names>R</given-names></name></person-group>. <article-title>A distributed brain network predicts general intelligence from resting-state human neuroimaging data</article-title>. <source>Philos Trans R Soc B Biol Sci</source>. (<year>2018</year>) <volume>373</volume>:<fpage>20170284</fpage>. doi: <pub-id pub-id-type="doi">10.1098/rstb.2017.0284</pub-id>, PMID: <pub-id pub-id-type="pmid">30104429</pub-id></mixed-citation>
      </ref>
      <ref id="ref75">
        <label>75.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz-Arigita</surname><given-names>EJ</given-names></name><name><surname>Menno</surname><given-names>MS</given-names></name><name><surname>Jessica</surname><given-names>SD</given-names></name><name><surname>Serge</surname><given-names>ARBR</given-names></name><name><surname>Erik</surname><given-names>M</given-names></name><name><surname>Frederik</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Loss of ‘Small-World’ Networks in Alzheimer’s Disease: Graph Analysis of FMRI Resting-State Functional Connectivity</article-title>. <source>PLoS ONE</source>. (<year>2010</year>) <volume>5</volume>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0013788</pub-id></mixed-citation>
      </ref>
      <ref id="ref76">
        <label>76.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brier</surname><given-names>MR</given-names></name><name><surname>Jewell</surname><given-names>BT</given-names></name><name><surname>Abraham</surname><given-names>ZS</given-names></name><name><surname>Tammie</surname><given-names>LB</given-names></name><name><surname>Dongyang</surname><given-names>Z</given-names></name><name><surname>Marcus</surname><given-names>ER</given-names></name><etal/></person-group>. <article-title>Loss of Intranetwork and Internetwork Resting State Functional Connections with Alzheimer’s Disease Progression</article-title>. <source>Journal of Neuroscience</source>. (<year>2012</year>) <volume>32</volume>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5698-11.2012</pub-id></mixed-citation>
      </ref>
      <ref id="ref77">
        <label>77.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fjell</surname><given-names>AM</given-names></name><name><surname>Sneve</surname><given-names>MH</given-names></name><name><surname>Grydeland</surname><given-names>H</given-names></name><name><surname>Storsve</surname><given-names>AB</given-names></name><name><surname>Walhovd</surname><given-names>KB</given-names></name></person-group>. <article-title>The disconnected brain and executive function decline in aging</article-title>. <source>Cereb Cortex</source>. (<year>2017</year>) <volume>27</volume>:<fpage>2303</fpage>–<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cercor/bhw082</pub-id>, PMID: <pub-id pub-id-type="pmid">27073220</pub-id></mixed-citation>
      </ref>
      <ref id="ref78">
        <label>78.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khasawinah</surname><given-names>S</given-names></name><name><surname>Chuang</surname><given-names>Y-F</given-names></name><name><surname>Caffo</surname><given-names>B</given-names></name><name><surname>Erickson</surname><given-names>KI</given-names></name><name><surname>Kramer</surname><given-names>AF</given-names></name><name><surname>Carlson</surname><given-names>MC</given-names></name></person-group>. <article-title>The association between functional connectivity and cognition in older adults</article-title>. <source>Journal of Systems and Integrative Neuroscience</source>. (<year>2017</year>) <volume>3</volume>:<fpage>3</fpage>. doi: <pub-id pub-id-type="doi">10.15761/jsin.1000164</pub-id></mixed-citation>
      </ref>
      <ref id="ref79">
        <label>79.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Rizzo</surname><given-names>AL</given-names></name><name><surname>Sorg</surname><given-names>C</given-names></name><name><surname>Napiórkowski</surname><given-names>N</given-names></name><name><surname>Neitzel</surname><given-names>J</given-names></name><name><surname>Menegaux</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Decreased Cingulo-Opercular network functional connectivity mediates the impact of aging on visual processing speed</article-title>. <source>Neurobiol Aging</source>. (<year>2019</year>) <volume>73</volume>:<fpage>50</fpage>–<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.09.014</pub-id>, PMID: <pub-id pub-id-type="pmid">30317033</pub-id></mixed-citation>
      </ref>
      <ref id="ref80">
        <label>80.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La</surname><given-names>C</given-names></name><name><surname>Mossahebi</surname><given-names>P</given-names></name><name><surname>Nair</surname><given-names>VA</given-names></name><name><surname>Bendlin</surname><given-names>BB</given-names></name><name><surname>Birn</surname><given-names>R</given-names></name><name><surname>Meyerand</surname><given-names>ME</given-names></name><etal/></person-group>. <article-title>Age-related changes in inter-network connectivity by component analysis</article-title>. <source>Front Aging Neurosci</source>. (<year>2015</year>) <volume>7</volume>:<fpage>237</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2015.00237</pub-id><pub-id pub-id-type="pmid">26733864</pub-id></mixed-citation>
      </ref>
      <ref id="ref81">
        <label>81.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>MY</given-names></name><name><surname>Park</surname><given-names>DC</given-names></name><name><surname>Savalia</surname><given-names>NK</given-names></name><name><surname>Petersen</surname><given-names>SE</given-names></name><name><surname>Wig</surname><given-names>GS</given-names></name></person-group>. <article-title>Decreased segregation of brain systems across the healthy adult lifespan</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2014</year>) <volume>111</volume>:<fpage>E4997</fpage>–<lpage>5006</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1415122111</pub-id>, PMID: <pub-id pub-id-type="pmid">25368199</pub-id></mixed-citation>
      </ref>
      <ref id="ref82">
        <label>82.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraft</surname><given-names>JN</given-names></name><name><surname>Hausman</surname><given-names>HK</given-names></name><name><surname>Hardcastle</surname><given-names>C</given-names></name><name><surname>Albizu</surname><given-names>A</given-names></name><name><surname>O’Shea</surname><given-names>A</given-names></name><name><surname>Evangelista</surname><given-names>ND</given-names></name><etal/></person-group>. <article-title>Task-based functional connectivity of the useful field of view (UFOV) FMRI task</article-title>. <source>GeroScience</source>. (<year>2022</year>) <volume>45</volume>:<fpage>293</fpage>–<lpage>309</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11357-022-00632-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35948860</pub-id></mixed-citation>
      </ref>
      <ref id="ref83">
        <label>83.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naqvi</surname><given-names>NH</given-names></name><name><surname>Gaznick</surname><given-names>N</given-names></name><name><surname>Tranel</surname><given-names>D</given-names></name><name><surname>Bechara</surname><given-names>A</given-names></name></person-group>. <article-title>The insula: a critical neural substrate for craving and drug seeking under conflict and risk</article-title>. <source>Ann N Y Acad Sci</source>. (<year>2014</year>) <volume>1316</volume>:<fpage>53</fpage>–<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1111/nyas.12415</pub-id>, PMID: <pub-id pub-id-type="pmid">24690001</pub-id></mixed-citation>
      </ref>
      <ref id="ref84">
        <label>84.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>MT</given-names></name><name><surname>McHugh</surname><given-names>MJ</given-names></name><name><surname>Pariyadath</surname><given-names>V</given-names></name><name><surname>Stein</surname><given-names>EA</given-names></name></person-group>. <article-title>Resting state functional connectivity in addiction: lessons learned and a road ahead</article-title>. <source>NeuroImage</source>. (<year>2012</year>) <volume>62</volume>:<fpage>2281</fpage>–<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.117</pub-id><pub-id pub-id-type="pmid">22326834</pub-id></mixed-citation>
      </ref>
      <ref id="ref85">
        <label>85.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Gardner</surname><given-names>K</given-names></name><name><surname>Lowe</surname><given-names>MJ</given-names></name></person-group>. <article-title>Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study</article-title>. <source>J Neuropsych Clin Neurosci</source>. (<year>2007</year>) <volume>19</volume>:<fpage>274</fpage>–<lpage>282</lpage>., PMID: <pub-id pub-id-type="pmid">16788060</pub-id></mixed-citation>
      </ref>
      <ref id="ref86">
        <label>86.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Weidan</surname><given-names>P</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name></person-group>. <article-title>Functional alterations of Fronto-limbic circuit and default mode network Systems in First-Episode, drug-Naïve patients with major depressive disorder: a meta-analysis of resting-state FMRI data</article-title>. <source>J Affect Disord</source>. (<year>2016</year>) <volume>206</volume>:<fpage>280</fpage>–<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jad.2016.09.005</pub-id>, PMID: <pub-id pub-id-type="pmid">27639862</pub-id></mixed-citation>
      </ref>
      <ref id="ref87">
        <label>87.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbetta</surname><given-names>M</given-names></name><name><surname>Shulman</surname><given-names>GL</given-names></name></person-group>. <article-title>Control of goal-directed and stimulus-driven attention in the brain</article-title>. <source>Nat Rev Neurosci</source>. (<year>2002</year>) <volume>3</volume>:<fpage>201</fpage>–<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrn755</pub-id><pub-id pub-id-type="pmid">11994752</pub-id></mixed-citation>
      </ref>
      <ref id="ref88">
        <label>88.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>MD</given-names></name><name><surname>Corbetta</surname><given-names>M</given-names></name><name><surname>Snyder</surname><given-names>AZ</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Raichle</surname><given-names>ME</given-names></name></person-group>. <article-title>Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>2006</year>) <volume>103</volume>:<fpage>10046</fpage>–<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0604187103</pub-id>, PMID: <pub-id pub-id-type="pmid">16788060</pub-id></mixed-citation>
      </ref>
      <ref id="ref89">
        <label>89.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group>. <article-title>Abnormal functional connectivity and effective connectivity between the default mode network and attention networks in patients with alcohol-use disorder</article-title>. <source>Acta Radiol</source>. (<year>2021</year>) <volume>62</volume>:<fpage>251</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0284185120923270</pub-id>, PMID: <pub-id pub-id-type="pmid">32423229</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
